Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 ZMIZ2 RGPD3 RGPD2 RANBP2 RGPD8	1.75e-07	20	266	6	GO:0061665
GeneOntologyMolecularFunction	small GTPase binding	RGPD4 GAPVD1 ERC1 RALBP1 RGPD3 RIC1 IPO5 RGPD2 RANBP2 DMXL2 ANKFY1 RGPD8 ARHGAP1 IPO9 CSE1L C9orf72 PLCE1	1.58e-06	321	266	17	GO:0031267
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RGPD4 FKBP9 RGPD3 RGPD2 RANBP2 RGPD8 PPIL4	4.21e-06	50	266	7	GO:0003755
GeneOntologyMolecularFunction	cis-trans isomerase activity	RGPD4 FKBP9 RGPD3 RGPD2 RANBP2 RGPD8 PPIL4	6.28e-06	53	266	7	GO:0016859
GeneOntologyMolecularFunction	GTPase binding	RGPD4 GAPVD1 ERC1 RALBP1 RGPD3 RIC1 IPO5 RGPD2 RANBP2 DMXL2 ANKFY1 RGPD8 ARHGAP1 IPO9 CSE1L C9orf72 PLCE1	7.33e-06	360	266	17	GO:0051020
GeneOntologyMolecularFunction	SUMO transferase activity	RGPD4 ZMIZ2 RGPD3 RGPD2 RANBP2 RGPD8	7.36e-06	36	266	6	GO:0019789
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RGPD4 ACAP1 GAPVD1 GRIPAP1 GMIP SLIT2 ASAP2 ARHGAP31 RALBP1 RGPD3 ARHGEF6 RIC1 IPO5 RGPD2 RANBP2 RGPD8 ARHGAP1 NPRL3 C9orf72 PLCE1	1.65e-05	507	266	20	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RGPD4 ACAP1 GAPVD1 GRIPAP1 GMIP SLIT2 ASAP2 ARHGAP31 RALBP1 RGPD3 ARHGEF6 RIC1 IPO5 RGPD2 RANBP2 RGPD8 ARHGAP1 NPRL3 C9orf72 PLCE1	1.65e-05	507	266	20	GO:0030695
GeneOntologyMolecularFunction	GTPase activator activity	RGPD4 ACAP1 GAPVD1 GMIP ASAP2 ARHGAP31 RALBP1 RGPD3 ARHGEF6 RGPD2 RANBP2 RGPD8 ARHGAP1 NPRL3	2.44e-05	279	266	14	GO:0005096
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.70e-08	9	260	5	GO:0033133
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	7.33e-08	10	260	5	GO:1903301
GeneOntologyBiologicalProcess	intracellular transport	RGPD4 GRIPAP1 CLTCL1 ERC1 USP9X PEX6 MPDZ FYCO1 NUP58 HM13 SLC30A2 NUP205 ARL5C JUP NOP9 DST MDN1 AP1B1 RGPD3 CLTC PKD1 BSN HEATR5B RIC1 IPO5 RGPD2 RANBP2 ANKFY1 RGPD8 ANK3 COG7 SYNE1 GRAMD1A NUMA1 ICE1 TACC2 TRAPPC8 ANKRD50 CPT1B ARHGAP1 IPO9 CSE1L C9orf72 RIOK2	1.14e-07	1496	260	44	GO:0046907
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RGPD3 IPO5 RGPD2 RANBP2 RGPD8	1.27e-07	20	260	6	GO:0006607
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.63e-07	13	260	5	GO:0033131
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.59e-07	14	260	5	GO:1903299
GeneOntologyBiologicalProcess	protein peptidyl-prolyl isomerization	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 PPIL4	7.45e-06	38	260	6	GO:0000413
GeneOntologyBiologicalProcess	peptidyl-proline modification	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 PPIL4	5.89e-05	54	260	6	GO:0018208
GeneOntologyBiologicalProcess	ureteric bud development	SIX4 SLIT2 KIF26B LAMA5 CAT GDF11 SMAD1 SMAD5	6.36e-05	107	260	8	GO:0001657
GeneOntologyBiologicalProcess	intracellular protein transport	RGPD4 GRIPAP1 CLTCL1 USP9X PEX6 MPDZ NUP58 HM13 ARL5C JUP AP1B1 RGPD3 CLTC PKD1 RIC1 IPO5 RGPD2 RANBP2 RGPD8 COG7 ICE1 IPO9 CSE1L	6.82e-05	740	260	23	GO:0006886
GeneOntologyBiologicalProcess	mesonephric tubule development	SIX4 SLIT2 KIF26B LAMA5 CAT GDF11 SMAD1 SMAD5	7.74e-05	110	260	8	GO:0072164
GeneOntologyBiologicalProcess	mesonephric epithelium development	SIX4 SLIT2 KIF26B LAMA5 CAT GDF11 SMAD1 SMAD5	7.74e-05	110	260	8	GO:0072163
GeneOntologyBiologicalProcess	mesonephros development	SIX4 SLIT2 KIF26B LAMA5 CAT GDF11 SMAD1 SMAD5	9.36e-05	113	260	8	GO:0001823
GeneOntologyBiologicalProcess	nuclear transport	RGPD4 NUP58 NUP205 JUP NOP9 MDN1 RGPD3 PKD1 IPO5 RGPD2 RANBP2 RGPD8 IPO9 CSE1L RIOK2	9.80e-05	378	260	15	GO:0051169
GeneOntologyBiologicalProcess	nucleocytoplasmic transport	RGPD4 NUP58 NUP205 JUP NOP9 MDN1 RGPD3 PKD1 IPO5 RGPD2 RANBP2 RGPD8 IPO9 CSE1L RIOK2	9.80e-05	378	260	15	GO:0006913
GeneOntologyBiologicalProcess	nuclear export	RGPD4 NOP9 MDN1 RGPD3 PKD1 RGPD2 RANBP2 RGPD8 CSE1L RIOK2	1.25e-04	185	260	10	GO:0051168
GeneOntologyBiologicalProcess	regulation of carbohydrate metabolic process	RGPD4 PASK PHKG2 RGPD3 CLTC RGPD2 RANBP2 RGPD8 UGT1A1 SLC25A12 MTOR	1.77e-04	231	260	11	GO:0006109
GeneOntologyBiologicalProcess	protein import into nucleus	RGPD4 NUP58 JUP RGPD3 IPO5 RGPD2 RANBP2 RGPD8 IPO9 CSE1L	1.92e-04	195	260	10	GO:0006606
GeneOntologyBiologicalProcess	kidney epithelium development	SIX4 SLIT2 KIF26B LAMA5 CAT HES5 GDF11 SMAD1 SMAD5	2.21e-04	162	260	9	GO:0072073
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.62e-08	8	262	5	GO:1990723
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	7.13e-08	10	262	5	GO:0044614
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 NSMCE4A	1.70e-07	21	262	6	GO:0106068
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-07	14	262	5	GO:0005642
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	2.23e-06	18	262	5	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.96e-06	20	262	5	GO:0042405
GeneOntologyCellularComponent	nuclear pore	RGPD4 NUP58 NUP205 RGPD3 IPO5 RGPD2 RANBP2 RGPD8	4.05e-05	101	262	8	GO:0005643
MousePheno	abnormal morula morphology	RGPD4 SPTB RGPD3 RGPD2 RANBP2 RGPD8	1.71e-06	26	206	6	MP:0012058
MousePheno	elevated level of mitotic sister chromatid exchange	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	2.53e-06	16	206	5	MP:0003701
MousePheno	decreased tumor latency	RGPD4 RGPD3 DCLRE1A RGPD2 RANBP2 RGPD8	4.21e-06	30	206	6	MP:0010308
MousePheno	increased incidence of tumors by chemical induction	RGPD4 NLRP12 CEACAM5 CUL9 RGPD3 RGPD2 RANBP2 RGPD8 CAT MAP3K6 AKR1B15	7.53e-06	141	206	11	MP:0004499
MousePheno	abnormal tumor latency	RGPD4 RGPD3 DCLRE1A RGPD2 RANBP2 RGPD8	9.08e-06	34	206	6	MP:0010307
MousePheno	increased incidence of induced tumors	RGPD4 NLRP12 CEACAM5 CUL9 BLM RGPD3 RGPD2 RANBP2 RGPD8 CAT MAP3K6 AKR1B15	9.70e-06	173	206	12	MP:0002021
MousePheno	abnormal incidence of induced tumors	RGPD4 NLRP12 CEACAM5 CUL9 BLM SERPINB9 RGPD3 RGPD2 RANBP2 RGPD8 CAT MAP3K6 TLR4 AKR1B15 PLCE1	1.08e-05	269	206	15	MP:0013151
MousePheno	increased sarcoma incidence	RGPD4 CUL9 USP44 RGPD3 DCLRE1A RGPD2 RANBP2 RGPD8 SMARCB1	1.93e-05	102	206	9	MP:0002032
MousePheno	abnormal blastocyst formation	RGPD4 RGPD3 RGPD2 RANBP2 EXOSC10 RGPD8	2.07e-05	39	206	6	MP:0012128
MousePheno	abnormal brain development	TRABD2B CTNNAL1 AGO2 HM13 ARL5C TBATA CFAP54 MIB1 PKD1 ASPM DNAH5 ODAD3 BAG6 LAMA5 APOB ADGRA2 IPO9 CSF1R BRD2 MTOR TTL LRRCC1 SMARCB1 SMAD5	2.36e-05	638	206	24	MP:0000913
MousePheno	failure of blastocyst formation	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	8.23e-05	31	206	5	MP:0012129
MousePheno	abnormal tumor incidence	RGPD4 NLRP12 CEACAM5 CUL9 HM13 BLM USP44 SERPINB9 RGPD3 PKD1 DCLRE1A RGPD2 RANBP2 DMXL2 RGPD8 CAT MAP3K6 TLR4 FSHR AKR1B15 SMARCB1 PLCE1	1.74e-04	635	206	22	MP:0002019
MousePheno	increased lung tumor incidence	RGPD4 CUL9 USP44 RGPD3 DCLRE1A RGPD2 RANBP2 RGPD8	1.82e-04	107	206	8	MP:0008014
MousePheno	increased respiratory system tumor incidence	RGPD4 CUL9 USP44 RGPD3 DCLRE1A RGPD2 RANBP2 RGPD8	1.82e-04	107	206	8	MP:0010298
MousePheno	failure of blastocyst to hatch from the zona pellucida	RGPD4 SPTB NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMARCB1	1.82e-04	107	206	8	MP:0003694
MousePheno	increased liver tumor incidence	RGPD4 CUL9 USP44 RGPD3 RGPD2 RANBP2 RGPD8 CAT	2.34e-04	111	206	8	MP:0008019
MousePheno	increased hepatobiliary system tumor incidence	RGPD4 CUL9 USP44 RGPD3 RGPD2 RANBP2 RGPD8 CAT	2.34e-04	111	206	8	MP:0010297
MousePheno	abnormal tumor susceptibility	RGPD4 NLRP12 CEACAM5 CUL9 HM13 BLM USP44 SERPINB9 RGPD3 PKD1 DCLRE1A RGPD2 RANBP2 DMXL2 RGPD8 CAT MAP3K6 TLR4 FSHR AKR1B15 SMARCB1 PLCE1	2.41e-04	650	206	22	MP:0002166
MousePheno	abnormal eye physiology	RGPD4 ZHX3 PEX6 ADGRV1 DST PXDN RGPD3 PLA2G6 SLITRK6 RGPD2 RANBP2 RGPD8 COG7 SYNE1 RBP3 NFKBIZ OPA3 OAT XRCC5 CNGB3 MACF1	2.45e-04	606	206	21	MP:0005253
MousePheno	abnormal blastocyst hatching	RGPD4 SPTB NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMARCB1	2.65e-04	113	206	8	MP:0003693
MousePheno	aneuploidy	RGPD4 USP44 RGPD3 RGPD2 RANBP2 RGPD8	2.69e-04	61	206	6	MP:0004024
MousePheno	interrupted aortic arch	ERMP1 DNAH5 LAMA5 BRD2 NPRL3	3.22e-04	41	206	5	MP:0004157
MousePheno	increased physiological sensitivity to xenobiotic	RGPD4 NLRP12 CEACAM5 CUL9 RGPD3 RGPD2 RANBP2 RGPD8 GRIA2 CAT MAP3K6 AKR1B15 N4BP1	3.26e-04	286	206	13	MP:0008873
Domain	Ran_BP1	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.75e-07	12	261	5	PF00638
Domain	RANBD1	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.75e-07	12	261	5	PS50196
Domain	RanBD	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.02e-07	13	261	5	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.02e-07	13	261	5	IPR000156
Domain	GCC2_Rab_bind	RGPD4 RGPD3 RGPD2 RGPD8	1.26e-06	7	261	4	IPR032023
Domain	Rab_bind	RGPD4 RGPD3 RGPD2 RGPD8	1.26e-06	7	261	4	PF16704
Domain	-	RGPD4 CLTCL1 CFAP54 RGPD3 CLTC TTC38 NAA16 RGPD2 RANBP2 RGPD8 P3H3 TRAPPC8 KLC4 MTOR	1.35e-06	207	261	14	1.25.40.10
Domain	ARM-type_fold	CLTCL1 NEK10 USP9X CUL9 FOCAD JUP NOP9 AP1B1 PI4KA CLTC ASPM HEATR5B IPO5 MROH2A APOB IPO9 CSE1L MTOR	1.46e-06	339	261	18	IPR016024
Domain	CH	SPTB DST ASPM NAV2 UTRN ARHGEF6 SYNE1 MACF1	3.31e-06	65	261	8	SM00033
Domain	Ank	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	4.20e-06	228	261	14	PF00023
Domain	Cys-rich_flank_reg_C	LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 ADGRA2 TLR4	4.66e-06	90	261	9	IPR000483
Domain	LRRCT	LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 ADGRA2 TLR4	4.66e-06	90	261	9	SM00082
Domain	SPEC	SPTB DST UTRN SESTD1 SYNE1 MACF1	4.70e-06	32	261	6	SM00150
Domain	Spectrin/alpha-actinin	SPTB DST UTRN SESTD1 SYNE1 MACF1	4.70e-06	32	261	6	IPR018159
Domain	TPR-like_helical_dom	RGPD4 CLTCL1 CFAP54 RGPD3 CLTC TTC38 NAA16 RGPD2 RANBP2 RGPD8 P3H3 TRAPPC8 KLC4 MTOR	5.39e-06	233	261	14	IPR011990
Domain	CH	SPTB DST ASPM NAV2 UTRN ARHGEF6 SYNE1 MACF1	5.84e-06	70	261	8	PF00307
Domain	-	SPTB DST ASPM NAV2 UTRN ARHGEF6 SYNE1 MACF1	6.50e-06	71	261	8	1.10.418.10
Domain	Leu-rich_rpt	NLRP12 LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 NISCH TLR4 FSHR LRRCC1 NLRP4	6.75e-06	271	261	15	IPR001611
Domain	-	RGPD4 RGPD3 RGPD2 RGPD8	7.33e-06	10	261	4	1.10.220.60
Domain	CH	SPTB DST ASPM NAV2 UTRN ARHGEF6 SYNE1 MACF1	8.01e-06	73	261	8	PS50021
Domain	CH-domain	SPTB DST ASPM NAV2 UTRN ARHGEF6 SYNE1 MACF1	9.82e-06	75	261	8	IPR001715
Domain	Ank_2	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B ASB2	1.09e-05	215	261	13	PF12796
Domain	GRIP	RGPD4 RGPD3 RGPD2 RGPD8	1.14e-05	11	261	4	PF01465
Domain	Grip	RGPD4 RGPD3 RGPD2 RGPD8	1.14e-05	11	261	4	SM00755
Domain	ANK	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	1.26e-05	251	261	14	SM00248
Domain	ANK_REPEAT	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	1.38e-05	253	261	14	PS50088
Domain	Spectrin	SPTB DST UTRN SYNE1 MACF1	1.40e-05	23	261	5	PF00435
Domain	ACTININ_2	SPTB DST UTRN SYNE1 MACF1	1.40e-05	23	261	5	PS00020
Domain	ACTININ_1	SPTB DST UTRN SYNE1 MACF1	1.40e-05	23	261	5	PS00019
Domain	Actinin_actin-bd_CS	SPTB DST UTRN SYNE1 MACF1	1.40e-05	23	261	5	IPR001589
Domain	Ankyrin_rpt-contain_dom	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	1.44e-05	254	261	14	IPR020683
Domain	ANK_REP_REGION	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	1.44e-05	254	261	14	PS50297
Domain	GRIP	RGPD4 RGPD3 RGPD2 RGPD8	1.69e-05	12	261	4	PS50913
Domain	GRIP_dom	RGPD4 RGPD3 RGPD2 RGPD8	1.69e-05	12	261	4	IPR000237
Domain	Ankyrin_rpt	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B TNNI3K ASB2	2.04e-05	262	261	14	IPR002110
Domain	LRR	NLRP12 LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 LRRC30 ADGRA2 NISCH TLR4 LRRCC1	2.71e-05	201	261	12	PS51450
Domain	Spectrin_repeat	SPTB DST UTRN SYNE1 MACF1	4.63e-05	29	261	5	IPR002017
Domain	-	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B ASB2	4.90e-05	248	261	13	1.25.40.20
Domain	-	NLRP12 LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 NISCH TLR4 FSHR LRRCC1 NLRP4	4.90e-05	321	261	15	3.80.10.10
Domain	L_dom-like	NLRP12 LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 NISCH TLR4 FSHR LRRCC1 NLRP4	6.26e-05	328	261	15	IPR032675
Domain	-	NEK10 USP9X CUL9 JUP NOP9 AP1B1 ASPM HEATR5B IPO5 IPO9 CSE1L MTOR	7.12e-05	222	261	12	1.25.10.10
Domain	TPR	RGPD4 RGPD3 TTC38 NAA16 RGPD2 RANBP2 RGPD8 P3H3 KLC4 FEM1B	1.12e-04	165	261	10	PS50005
Domain	TPR_REGION	RGPD4 RGPD3 TTC38 NAA16 RGPD2 RANBP2 RGPD8 P3H3 KLC4 FEM1B	1.12e-04	165	261	10	PS50293
Domain	ARM-like	NEK10 USP9X CUL9 JUP NOP9 AP1B1 ASPM HEATR5B IPO5 MROH2A IPO9 CSE1L MTOR	1.16e-04	270	261	13	IPR011989
Domain	LRR_8	LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 TLR4	1.50e-04	171	261	10	PF13855
Domain	Clathrin_H-chain_propeller_rpt	CLTCL1 CLTC	1.95e-04	2	261	2	IPR022365
Domain	L27_2	MPDZ PATJ	1.95e-04	2	261	2	PF09045
Domain	Clathrin_H-chain_propeller_N	CLTCL1 CLTC	1.95e-04	2	261	2	IPR001473
Domain	Clathrin_H-chain_link/propller	CLTCL1 CLTC	1.95e-04	2	261	2	IPR016025
Domain	L27_2	MPDZ PATJ	1.95e-04	2	261	2	IPR015132
Domain	FSH_rcpt	SLIT2 FSHR	1.95e-04	2	261	2	IPR002272
Domain	Clathrin-link	CLTCL1 CLTC	1.95e-04	2	261	2	PF09268
Domain	-	CLTCL1 CLTC	1.95e-04	2	261	2	2.130.10.110
Domain	Clathrin_heavy_chain	CLTCL1 CLTC	1.95e-04	2	261	2	IPR016341
Domain	Clathrin_propel	CLTCL1 CLTC	1.95e-04	2	261	2	PF01394
Domain	Clathrin_H-chain_linker_core	CLTCL1 CLTC	1.95e-04	2	261	2	IPR015348
Domain	AAA+_ATPase	ABCA13 PEX6 ABCA9 MDN1 NAV2 DNAH5 DNAH6 RAD51D RFC4	1.95e-04	144	261	9	IPR003593
Domain	AAA	ABCA13 PEX6 ABCA9 MDN1 NAV2 DNAH5 DNAH6 RAD51D RFC4	1.95e-04	144	261	9	SM00382
Domain	Leu-rich_rpt_typical-subtyp	LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 TLR4	1.99e-04	177	261	10	IPR003591
Domain	LRR_TYP	LRRC70 SLIT2 PXDN PKD1 SLITRK6 LRIT2 MXRA5 LRRC30 ADGRA2 TLR4	1.99e-04	177	261	10	SM00369
Domain	LRR_1	LRRC70 SLIT2 PXDN SLITRK6 LRIT2 LRRC30 ADGRA2 NISCH TLR4 FSHR LRRCC1	2.69e-04	219	261	11	PF00560
Domain	LRRNT	LRRC70 SLIT2 PXDN PKD1 LRIT2 MXRA5 FSHR	4.50e-04	98	261	7	SM00013
Domain	LRRNT	LRRC70 SLIT2 PXDN PKD1 LRIT2 MXRA5 FSHR	4.50e-04	98	261	7	IPR000372
Domain	HRDC	BLM EXOSC10	5.78e-04	3	261	2	PS50967
Domain	Pept_M24_MAP	METAP1D METAP2	5.78e-04	3	261	2	IPR001714
Domain	HRDC	BLM EXOSC10	5.78e-04	3	261	2	SM00341
Domain	Clathrin_H-chain_linker	CLTCL1 CLTC	5.78e-04	3	261	2	IPR012331
Domain	DUF4071	MAP3K15 MAP3K6	5.78e-04	3	261	2	PF13281
Domain	HRDC	BLM EXOSC10	5.78e-04	3	261	2	PF00570
Domain	DUF4071	MAP3K15 MAP3K6	5.78e-04	3	261	2	IPR025136
Domain	CLH	CLTCL1 CLTC	5.78e-04	3	261	2	SM00299
Domain	Kinase-like_dom	EPHA6 NEK10 PASK PHKG2 DST PI4KA MAP3K15 ANKK1 CHD9 STK32C MAP3K6 MKNK1 TNNI3K CSF1R MTOR MACF1 PEAK1 RIOK2	6.47e-04	542	261	18	IPR011009
Domain	IMPORTIN_B_NT	IPO5 IPO9 CSE1L	8.76e-04	14	261	3	PS50166
Domain	ATPase_dyneun-rel_AAA	MDN1 DNAH5 DNAH6	8.76e-04	14	261	3	IPR011704
Domain	AAA_5	MDN1 DNAH5 DNAH6	8.76e-04	14	261	3	PF07728
Domain	HRDC_dom	BLM EXOSC10	1.15e-03	4	261	2	IPR002121
Domain	TPR-contain_dom	RGPD4 RGPD3 NAA16 RGPD2 RANBP2 RGPD8 P3H3 KLC4	1.25e-03	150	261	8	IPR013026
Domain	Importin-beta_N	IPO5 IPO9 CSE1L	1.59e-03	17	261	3	IPR001494
Domain	HRDC-like	BLM EXOSC10	1.89e-03	5	261	2	IPR010997
Domain	TPR	RGPD4 RGPD3 NAA16 RGPD2 RANBP2 RGPD8 KLC4	2.26e-03	129	261	7	SM00028
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	RGPD4 AGO2 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	7.50e-08	41	195	8	MM15200
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	RGPD4 NUP58 NUP205 BLM RGPD3 RGPD2 RANBP2 RGPD8 PHC1 NSMCE4A	2.31e-07	84	195	10	MM14929
Pathway	REACTOME_GENE_SILENCING_BY_RNA	RGPD4 AGO2 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-07	49	195	8	MM14837
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.10e-06	40	195	7	MM14945
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 PHC1	1.23e-06	58	195	8	MM15149
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.56e-06	42	195	7	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.84e-06	43	195	7	MM14609
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 PHC1	2.99e-06	65	195	8	MM15147
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	3.43e-06	47	195	7	MM14939
Pathway	BIOCARTA_RANBP2_PATHWAY	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.56e-06	18	195	5	MM1549
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	5.25e-06	50	195	7	MM14610
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	6.02e-06	51	195	7	MM15151
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.01e-05	55	195	7	MM14917
Pathway	REACTOME_SNRNP_ASSEMBLY	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-05	58	195	7	MM14736
Pathway	REACTOME_RHOU_GTPASE_CYCLE	USP9X DST ARHGAP31 CLTC ARHGEF6 PEAK1	1.45e-05	39	195	6	MM15607
Pathway	REACTOME_RHOU_GTPASE_CYCLE	USP9X DST ARHGAP31 CLTC ARHGEF6 PEAK1	1.68e-05	40	195	6	M41816
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 MTOR	4.00e-05	92	195	8	MM14951
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	6.56e-05	73	195	7	MM14948
Pathway	REACTOME_SUMOYLATION	RGPD4 NUP58 NUP205 BLM RGPD3 RGPD2 RANBP2 RGPD8 PHC1 NSMCE4A	1.21e-04	169	195	10	MM14919
Pathway	REACTOME_GLUCOSE_METABOLISM	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.38e-04	82	195	7	MM15394
Pathway	REACTOME_MITOTIC_PROPHASE	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 NUMA1	1.83e-04	114	195	8	MM15361
Pathway	REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	RGPD4 NUP58 NUP205 RGPD3 RGPD2 RANBP2 RGPD8	1.86e-04	86	195	7	MM15413
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	GTF2A1 SMARCB1 SMARCC2	5.23e-04	12	195	3	M22006
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	NUP58 NUP205 BLM RANBP2 PHC1 NSMCE4A	6.81e-04	77	195	6	M27226
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 TPP2 AGO2 ERC1 USP9X MPDZ FYCO1 EDC4 DST MDN1 AP1B1 PI4KA RGPD3 CLTC BSN RGPD2 SESTD1 RANBP2 DMXL2 ANKFY1 RGPD8 ANK3 SYNE1 NUMA1 GRIA2 XRCC5 MTOR NISCH SMARCC2 MACF1	1.11e-10	963	268	30	28671696
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ZHX3 ERC1 KIAA0232 ADGRV1 PASK DST CLCN6 NAV2 DMXL2 ANKFY1 SYNE1 ADGRA2 MACF1 AKAP11 NIN	2.92e-10	225	268	15	12168954
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 ANK3	3.25e-10	13	268	6	31427429
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPP2 GAPVD1 USP9X CUL9 POGZ EDC4 NUP205 BLM DST MDN1 AP1B1 CLTC UTRN IPO5 RANBP2 EXOSC10 MTHFD1L NUMA1 OAT XRCC5 CSE1L MTOR SMARCC2 MACF1	3.54e-10	653	268	24	22586326
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	9037092
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	21205196
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	24403063
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	23536549
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	22821000
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	38838144
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	38657106
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	25187515
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	8603673
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	26632511
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	23818861
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	5.43e-10	7	268	5	20682751
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	GAPVD1 TBRG4 AGO2 ERMP1 POGZ ADGRV1 NUP58 NUP205 PASK DST ARHGAP31 MIB1 NAV2 BSN LAMA5 ICE1 ANKRD50 ADGRA2 CAPRIN2 AKAP11 NIN	1.20e-09	529	268	21	14621295
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-09	8	268	5	21670213
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-09	8	268	5	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-09	8	268	5	21310149
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-09	8	268	5	22262462
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.44e-09	8	268	5	28745977
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	USP9X EDC4 JUP AGL CLTC BAG6 IPO5 COL6A3 RANBP2 MTHFD1L XRCC5 IPO9 CSE1L	1.61e-09	179	268	13	36261009
Pubmed	A human MAP kinase interactome.	KIAA0232 POGZ NUP58 JUP ASAP2 DST ARHGAP31 CLTC NAV2 RANBP2 ANK3 KIF26B SYNE1 STK32C MKNK1 GTF2A1 CSE1L MACF1 BICRAL TXLNG	1.64e-09	486	268	20	20936779
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ERC1 USP9X SPTB ANKRD49 CUL9 POGZ NUP58 FOCAD DST RALBP1 CLTC MIB1 PKD1 UROD UTRN METAP2 IPO5 COG2 SESTD1 USP13 DMXL2 ANK3 SYNE1 CHD9 OAT ARHGAP1 BRD2 GUCY1B1 NISCH LRRCC1 FIBP MACF1 TXLNG	1.68e-09	1285	268	33	35914814
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	28100513
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	17887960
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	9733766
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	18394993
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	10601307
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	3.22e-09	9	268	5	28877029
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.39e-09	10	268	5	16332688
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.39e-09	10	268	5	27160050
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.39e-09	10	268	5	8857542
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.39e-09	10	268	5	21859863
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TPP2 AGO2 ERC1 USP9X SPTB FKBP9 EDC4 JMY JUP DST CLCN6 AP1B1 PI4KA CLTC BSN DNAH6 UTRN SLC25A23 METAP2 IPO5 DMXL2 ANK3 SYNE1 RBP3 GRIA2 OPA3 OAT CSE1L SLC25A12 NISCH LRRCC1 SMARCC2 MACF1 PEAK1	6.55e-09	1431	268	34	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RGPD4 MYH8 CLTCL1 ERC1 SLC30A2 NUP205 DST MDN1 PXDN RGPD3 CLTC ASPM NAV2 OTUD3 BSN DNAH6 RGPD2 RANBP2 RGPD8 PCDHGB6 SYNE1 NUMA1 CCDC150 GRIA2 CAT APOB XRCC5 SLC25A12 BRD2 CAPRIN2 SMARCC2 MACF1 TUBD1 NSMCE4A	7.91e-09	1442	268	34	35575683
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	GAPVD1 USP9X EXOC3 NUP58 EDC4 NUP205 SLIT2 JUP NOP9 DST MDN1 PI4KA CLTC UCK2 HEATR5B UTRN BAG6 IPO5 RANBP2 EXOSC10 SYNE1 NUMA1 CAT XRCC5 CSE1L BRD2 SMARCC2 MACF1	8.37e-09	1024	268	28	24711643
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.16e-08	11	268	5	17069463
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.16e-08	11	268	5	34110283
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	1.16e-08	11	268	5	35771867
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MRPL44 EXOC3 MPDZ HM13 BLM PASK JUP MDN1 PI4KA CLTC MIB1 ASPM BAG6 DMXL2 EXOSC10 ANK3 MTHFD1L SYNE1 COQ5 GRAMD1A OAT TRAPPC8 XRCC5 ARHGAP1 GTF2A1 BRD2 CEP89 NISCH MACF1 AKAP11 PEAK1 C9orf72 TXLNG NIN	1.68e-08	1487	268	34	33957083
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	PDE3A SLIT2 DST MDN1 CLTC ASPM DNAH5 EXOSC10 RGPD8 SYNE1 NUMA1 SMARCC2 MACF1	4.02e-08	234	268	13	36243803
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	USP9X NUP205 MDN1 PI4KA CLTC MIB1 IPO5 RANBP2 MTHFD1L OAT CSE1L SLC25A12	4.92e-08	197	268	12	31620119
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	7.38e-08	15	268	5	14697343
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH8 SPTB DST RALBP1 AGL CLTC UTRN IPO5 COL6A3 RANBP2 DMXL2 EXOSC10 ANKFY1 SYNE1 PPHLN1 ANKRD50 MACF1 PLCE1	7.58e-08	497	268	18	23414517
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EXOC3 POGZ EDC4 BLM MDN1 UTRN IPO5 RANBP2 NUMA1 CHD9 RFC4 XRCC5 CSE1L BRD2 SMARCB1 SMARCC2	8.74e-08	394	268	16	27248496
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD3 RGPD2 RGPD8	1.18e-07	7	268	4	15710750
Pubmed	Functional proteomics mapping of a human signaling pathway.	ZBTB6 PEX6 SVEP1 JUP DST AP1B1 PKD1 UTRN BAG6 USP13 ANK3 TUSC3 PPIL4 LAMA5 TRIM69 MACF1 ASB2 SMAD1 SMAD5	2.07e-07	591	268	19	15231748
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GAPVD1 TBRG4 USP9X MRPL44 POGZ EDC4 NUP205 JUP NOP9 MDN1 PI4KA CLTC BSN DNAH5 BAG6 IPO5 RANBP2 ANKFY1 MTHFD1L SYNE1 NUMA1 PPIL4 OAT APOB RFC4 XRCC5 YARS2 IPO9 CSE1L MTOR PEAK1	2.26e-07	1425	268	31	30948266
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	AGO2 EXOC3 POGZ NUP205 BLM JUP DST MDN1 PI4KA CLTC MIB1 ASPM UTRN METAP2 BAG6 RANBP2 EXOSC10 ANKFY1 MTHFD1L NUMA1 PPIL4 CAT RFC4 XRCC5 IPO9 CSE1L SLC25A12 SMARCC2 MACF1 RIOK2	2.41e-07	1353	268	30	29467282
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	USP9X ASAP2 AP1B1 PI4KA CLTC SESTD1 DMXL2 ANK3 SYNE1 GRIA2 MTOR MACF1 AKAP11	3.34e-07	281	268	13	28706196
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	MYH8 DST HEATR5B SYNE1 MACF1	3.69e-07	20	268	5	21689717
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	RGPD4 NUP58 RGPD3 RGPD2 RANBP2 RGPD8	4.44e-07	38	268	6	12791264
Pubmed	Defining the membrane proteome of NK cells.	ACAP1 AGO2 CLTCL1 USP9X CYP20A1 FYCO1 ERMP1 EDC4 HM13 NUP205 SERPINB9 MDN1 PI4KA CLTC HEATR5B BAG6 IPO5 RANBP2 EXOSC10 MTHFD1L CAT XRCC5 PAPOLG IPO9 CSE1L MTOR NISCH	4.51e-07	1168	268	27	19946888
Pubmed	A protein interaction landscape of breast cancer.	TPP2 GAPVD1 USP9X CUL9 JUP SERPINB9 DST MDN1 PI4KA CLTC NAV2 IPO5 RAD51D ANK3 XRCC5 SLC25A12 SMARCB1 SMARCC2 MACF1	5.97e-07	634	268	19	34591612
Pubmed	Terminal differentiation of cortical neurons rapidly remodels RanGAP-mediated nuclear transport system.	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8	6.19e-07	22	268	5	27717094
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	GAPVD1 CTNNAL1 ERC1 USP9X EXOC3 MPDZ HM13 JUP DST IPO5 RANBP2 ANK3 NUMA1 ANKRD50 XRCC5 ARHGAP1 CSE1L MACF1 PEAK1 PATJ	7.52e-07	708	268	20	39231216
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZHX3 ERC1 KIAA0232 CUL9 POGZ FOCAD PXDN CLTC ANKFY1 SYNE1 FEM1B NISCH GPCPD1 MACF1 PLCE1	7.58e-07	407	268	15	12693553
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	GAPVD1 ERC1 MPDZ EDC4 PASK DST UTRN KIF26B MACF1 AKAP11 PEAK1	7.70e-07	209	268	11	36779422
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	GRIPAP1 ERC1 USP9X ANKRD49 EXOC3 CUL9 NUP58 BLM PI4KA CLTC ASPM BSN RGPD8 TACC2 PAPOLG MACF1 PATJ NIN	8.80e-07	588	268	18	38580884
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 GAPVD1 ERC1 POGZ JUP DST ZMIZ2 RGPD3 UTRN RGPD2 RANBP2 ANKFY1 RGPD8 ICE1 PHC1	1.06e-06	418	268	15	34709266
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GAPVD1 ERC1 KIAA0232 MPDZ EDC4 JUP DST MDN1 PI4KA NAV2 UTRN KIF26B STK32C KLC4 MAP3K6 IPO9 CEP89 MTOR MACF1 AKAP11 PEAK1 PATJ	1.10e-06	861	268	22	36931259
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	POGZ BLM MDN1 AP1B1 ZMIZ2 DCLRE1A RANBP2 PPIL4 CHD9 PPHLN1 BRD2	1.39e-06	222	268	11	37071664
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	AGO2 CLTCL1 ERC1 FYCO1 EDC4 DST MDN1 AP1B1 CLTC UTRN IPO5 ANK3 SYNE1 NUMA1 GPRIN3 XRCC5 ARHGAP1 CSE1L SMARCC2 MACF1 PEAK1	1.46e-06	807	268	21	30575818
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	TPP2 MPDZ SVEP1 DST AP1B1 PI4KA BAG6 DMXL2 ARHGAP1 IPO9 CSE1L MACF1 PEAK1	1.54e-06	322	268	13	26514267
Pubmed	Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.	MTOR SMAD1 SMAD5	1.80e-06	4	268	3	22452883
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CLTCL1 PEX6 CUL9 FYCO1 EDC4 FOCAD DST MDN1 PI4KA ZMIZ2 PKD1 NAV2 PLA2G6 TTC38 RIC1 CRYBG2 MTHFD1L LAMA5 ICE1 STK32C ADGRA2 BRD2 MTOR NISCH NPRL3	1.81e-06	1105	268	25	35748872
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TPP2 HDHD3 TBRG4 ERC1 USP9X JUP AP1B1 SLC7A6OS AGL CLTC UCK2 METAP2 BAG6 IPO5 RANBP2 EXOSC10 MTHFD1L NUMA1 TACC2 RFC4 XRCC5 YARS2 CSE1L SMARCC2 MACF1 RIOK2 TXLNG CWF19L1 RAVER1	1.87e-06	1415	268	29	28515276
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TBRG4 MRPL44 PEX6 HM13 BLM DST MDN1 PI4KA CLTC MIB1 BAG6 DDX4 IPO5 TUT4 RGPD8 MTHFD1L SYNE1 COQ5 GRAMD1A OAT CAT TACC2 XRCC5 YARS2 ARHGAP1 SLC25A12 NISCH AKAP11 C9orf72 RAVER1	1.91e-06	1496	268	30	32877691
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	TBRG4 MRPL44 EXOC3 EDC4 AP1B1 CLTC UCK2 BAG6 IPO5 COG2 EXOSC10 COG7 MTHFD1L NUMA1 IPO9 CSE1L RAVER1	1.99e-06	560	268	17	35241646
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	PDE3A TBRG4 ERC1 USP9X ZXDA BLM NAV2 BAG6 ARHGEF6 RANBP2 NUMA1 PPHLN1 TACC2 KLC4 TXLNG RAVER1	2.21e-06	503	268	16	16964243
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	GRIPAP1 PEX6 FYCO1 JUP DST PI4KA HEATR5B BAG6 RIC1 COG2 DMXL2 GRAMD1A ANKRD50 NISCH AKAP11 C9orf72	2.27e-06	504	268	16	34432599
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP9X EXOC3 BLM OTUD3 UTRN USP13 DMXL2 MTOR FIBP	2.28e-06	147	268	9	29576527
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TPP2 CTNNAL1 AGO2 ERC1 USP9X EXOC3 SIX4 BLM PI4KA CLTC MIB1 UTRN RANBP2 ANK3 GRAMD1A GPRIN3 ARHGAP1 IPO9 CSE1L BRD2 CEP89 PEAK1 RAVER1 NIN	2.42e-06	1049	268	24	27880917
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH8 GAPVD1 AGO2 MRPL44 PHKG2 DST AP1B1 RALBP1 UTRN SLC25A23 METAP2 ANKFY1 GRIA2 OAT MAP3K6 MKNK1 DHRS12 BRD2 CNGB3 FIBP AKAP11 RIOK2	2.70e-06	910	268	22	36736316
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	MPDZ GMIP NUP205 ASAP2 ARHGAP31 RALBP1 MIB1 UTRN ARHGEF6 IPO5 ANKFY1 NUMA1 PPIL4 CAT ARHGAP1 CSE1L SLC25A12 NISCH SMARCC2 PEAK1 PATJ RAVER1	3.00e-06	916	268	22	32203420
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 GRIPAP1 ERC1 USP9X EDC4 HM13 PI4KA RGPD3 CLTC BSN RGPD2 RANBP2 DMXL2 TUT4 RGPD8 ANK3 GRAMD1A GRIA2 OAT TACC2 CSE1L GUCY1B1 SMARCC2 MACF1 PEAK1	3.08e-06	1139	268	25	36417873
Pubmed	Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP.	CLTCL1 FYCO1 ASAP2 CLTC IPO5	3.19e-06	30	268	5	22963397
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	TPP2 CTU2 PDE3A FKBP9 ERMP1 HM13 JUP DST PXDN CLTC METAP2 IPO5 P3H3 MTHFD1L TUSC3 NUMA1 LAMA5 OAT CAT APOB XRCC5 ARHGAP1 SMARCB1 SMARCC2 MACF1 RIOK2 RAVER1	3.26e-06	1297	268	27	33545068
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PEX6 EXOC3 MPDZ GMIP NOP9 DST AP1B1 RIC1 USP13 DMXL2 ANKRD50 MAP3K6 NISCH PATJ RIOK2 CWF19L1 PLCE1 RAVER1	3.59e-06	650	268	18	38777146
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RGPD4 GAPVD1 EXOC3 POGZ EDC4 BLM RGPD3 CLTC MIB1 ASPM NAA16 IPO5 RGPD2 RANBP2 RGPD8 COG7 SYNE1 NUMA1 TACC2 YARS2 TRIM69 SMARCB1 SMARCC2 NSMCE4A RAVER1	3.92e-06	1155	268	25	20360068
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	GAPVD1 ZBTB6 CTNNAL1 ANKRD49 JUP PI4KA CLTC DCAF17 UTRN ARHGEF6 SESTD1 EXOSC10 ANK3 NFKBIZ APOB TACC2 ANKRD50 FEM1B TLR4 MACF1 PEAK1 KDM1B PATJ NLRP4	4.23e-06	1084	268	24	11544199
Pubmed	Congenital semilunar valvulogenesis defect in mice deficient in phospholipase C epsilon.	SMAD1 SMAD5 PLCE1	4.47e-06	5	268	3	15743817
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	GAPVD1 TBRG4 ERC1 USP9X EDC4 HM13 NUP205 SLIT2 PXDN AP1B1 PI4KA CLTC HEATR5B BAG6 RANBP2 GRAMD1A IPO9 CSE1L SLC25A12 MTOR NISCH RAVER1	4.68e-06	942	268	22	31073040
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	GAPVD1 LRRC70 ZNF831 NUP205 FOCAD JUP DST MDN1 PI4KA AGL CLTC PKD1 UTRN MXRA5 KIF26B KRT28 ICE1 CPT1B XRCC5	5.25e-06	736	268	19	29676528
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	CTNNAL1 EXOC3 JUP DST PI4KA UTRN ANK3 COQ5 GPRIN3 ANKRD50 CEP89 NISCH MACF1 PEAK1	5.80e-06	421	268	14	36976175
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ZHX3 GAPVD1 USP9X EXOC3 BLM MDN1 NAV2 BAG6 RIC1 ANK3 MTHFD1L NUMA1 CHD9 SLC25A12 SMARCB1	8.60e-06	497	268	15	36774506
Pubmed	Novel roles of Pkd2 in male reproductive system development.	PKD1 SMAD1 SMAD5	8.90e-06	6	268	3	24951251
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	CYBRD1 HLA-DMB USP9X KIAA0232 PEX6 ERMP1 NUP205 BLM FOCAD PASK MDN1 BAG6 COG2 COG7 MTHFD1L TUSC3 OPA3 OAT APOB SLC47A2 ZDHHC9 MACF1 CDH17	9.47e-06	1061	268	23	33845483
Pubmed	A physical interaction network of dengue virus and human proteins.	ERC1 DST APOB ANKRD50	9.69e-06	18	268	4	21911577
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	USP9X ANK3 MTOR SMARCC2	9.69e-06	18	268	4	33323119
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ZHX3 TBRG4 CTNNAL1 USP9X LRRC70 HM13 MDN1 AP1B1 MIB1 BSN MXRA5 ANKFY1 IPO9 SMARCB1 SMARCC2 CDH17 RAVER1	1.10e-05	638	268	17	31182584
Interaction	RGPD2 interactions	RGPD4 EXOC3 RGPD3 RGPD2 RANBP2 RGPD8 C9orf72	3.91e-08	27	260	7	int:RGPD2
Interaction	RGPD4 interactions	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 C9orf72	2.73e-07	22	260	6	int:RGPD4
Interaction	C2CD4B interactions	KIAA0232 MPDZ ADGRV1 PASK ICE1 MACF1 PATJ	1.40e-06	44	260	7	int:C2CD4B
Interaction	EPB41L4A interactions	MPDZ JUP DST MDN1 PI4KA MIB1 UTRN ANK3 CEP89 MACF1 PATJ	2.09e-06	140	260	11	int:EPB41L4A
Interaction	RGPD3 interactions	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 NUMA1 C9orf72	2.22e-06	47	260	7	int:RGPD3
Interaction	ZUP1 interactions	EXOC3 BLM JUP ASPM UTRN BAG6 IPO5 DMXL2 CAT CSE1L MTOR FIBP	2.83e-06	174	260	12	int:ZUP1
Interaction	HIF1AN interactions	GAPVD1 ANKRD49 FYCO1 BLM PLA2G6 IPO5 ANKK1 ANKFY1 ANK3 ANKRD50 FEM1B TNNI3K SLC25A12 CEP89 TXLNG RAVER1	3.96e-06	317	260	16	int:HIF1AN
Interaction	RGPD5 interactions	RGPD4 EXOC3 RGPD3 ODAD3 NPAS1 RGPD2 RANBP2 RGPD8 C9orf72	4.20e-06	96	260	9	int:RGPD5
Interaction	CCDC8 interactions	GAPVD1 USP9X EXOC3 CUL9 NUP205 SLIT2 JUP NOP9 DST MDN1 PI4KA CLTC UCK2 HEATR5B UTRN RANBP2 MROH2A NUMA1 CAT APOB XRCC5 CSE1L SMARCC2 MACF1	4.81e-06	656	260	24	int:CCDC8
Interaction	RGPD8 interactions	RGPD4 RGPD3 MIB1 NPAS1 RGPD2 RANBP2 RGPD8 C9orf72	4.98e-06	74	260	8	int:RGPD8
Interaction	TRIM33 interactions	ERC1 USP9X POGZ EDC4 JUP AGL CLTC BAG6 IPO5 COL6A3 RANBP2 MTHFD1L RFC4 XRCC5 IPO9 CSE1L SMARCC2 ZNF333 NIN	7.35e-06	453	260	19	int:TRIM33
Interaction	KCNA3 interactions	GAPVD1 CTNNAL1 ABCA13 ERC1 USP9X EXOC3 MPDZ FYCO1 HM13 JUP ASAP2 DST BSN DNAH5 IPO5 RANBP2 ANK3 NUMA1 CHD9 ANKRD50 XRCC5 PAPOLG ARHGAP1 CSE1L CAPRIN2 MACF1 PEAK1 PATJ	8.81e-06	871	260	28	int:KCNA3
Interaction	FLOT1 interactions	CTNNAL1 EXOC3 MPDZ GMIP HM13 JUP DST PI4KA UTRN ANK3 GPRIN3 ZDHHC23 CEP89 NISCH MACF1 PEAK1 PATJ TUBD1 NIN	1.43e-05	475	260	19	int:FLOT1
Interaction	RHOD interactions	USP9X SPTB EXOC3 NUP205 JUP MDN1 PI4KA CLTC UTRN ANKFY1 ANK3 KIF26B YARS2 ARHGAP1 CSE1L CEP89 MTOR NISCH FIBP MACF1 PEAK1	1.83e-05	572	260	21	int:RHOD
Interaction	RHOF interactions	USP9X EXOC3 MPDZ NUP205 JUP MDN1 PI4KA CLTC UCK2 UTRN ANKFY1 ANK3 KIF26B ANKRD50 YARS2 ARHGAP1 CSE1L CEP89 MTOR NISCH FIBP MACF1 PEAK1	2.26e-05	673	260	23	int:RHOF
Interaction	GJA1 interactions	CTNNAL1 USP9X EXOC3 JUP DST PI4KA CLTC MIB1 UTRN ANK3 GPRIN3 APOB TRAPPC8 ARHGAP1 TRIM69 SLC25A12 CEP89 NISCH FSHR MACF1 PEAK1	2.42e-05	583	260	21	int:GJA1
Interaction	RMC1 interactions	AGO2 USP9X FYCO1 GMIP JUP BAG6 RANBP2 MTHFD1L STK32C CSE1L	2.90e-05	152	260	10	int:RMC1
Interaction	RP2 interactions	OTUD3 BAG6 DMXL2 COG7 TUSC3 CSE1L ZDHHC23 MTOR	3.18e-05	95	260	8	int:RP2
Interaction	SIRT7 interactions	TPP2 GAPVD1 USP9X CUL9 POGZ EDC4 NUP205 BLM DST MDN1 AP1B1 CLTC UTRN IPO5 RANBP2 EXOSC10 MTHFD1L NUMA1 OAT XRCC5 CSE1L MTOR SMARCC2 MACF1	3.78e-05	744	260	24	int:SIRT7
Interaction	RGPD1 interactions	RGPD4 RGPD3 RGPD2 RANBP2 RGPD8 C9orf72	3.82e-05	49	260	6	int:RGPD1
Interaction	ANKRD55 interactions	USP9X NUP205 MDN1 PI4KA CLTC MIB1 IPO5 RANBP2 MTHFD1L OAT CSE1L SLC25A12	4.32e-05	228	260	12	int:ANKRD55
Interaction	VCL interactions	MPDZ EDC4 FOCAD PASK JUP DST AGL CLTC PKD1 PPHLN1 MACF1 PEAK1 C9orf72 RAVER1	4.55e-05	305	260	14	int:VCL
Interaction	RAN interactions	RGPD4 NUP58 NUP205 ASAP2 AGL RGPD3 IPO5 RGPD2 RANBP2 RGPD8 NUMA1 IPO9 CSE1L SMARCB1 SMARCC2 ASB2 C9orf72 SMAD1	4.88e-05	475	260	18	int:RAN
Interaction	DTNBP1 interactions	EXOC3 DST ASPM IPO5 TRIM2 COG7 SYNE1 TRIM69 MACF1 BICRAL	4.99e-05	162	260	10	int:DTNBP1
Interaction	C11orf52 interactions	CTNNAL1 EXOC3 MPDZ JUP DST PI4KA UTRN ANK3 GPRIN3 ANKRD50 CEP89 NISCH MACF1 PEAK1	5.62e-05	311	260	14	int:C11orf52
Interaction	MTNR1B interactions	DST AP1B1 PI4KA DMXL2 ARHGAP1 IPO9 CSE1L MACF1 PEAK1	6.55e-05	135	260	9	int:MTNR1B
Interaction	NPTN interactions	TBRG4 CLTCL1 EDC4 FOCAD MDN1 PI4KA HEATR5B COG2 DMXL2 COG7 COQ5 CSE1L MTOR	7.04e-05	278	260	13	int:NPTN
Interaction	INSYN1 interactions	CTNNAL1 ERC1 EXOC3 AP1B1 UTRN COG2 REXO5 RGPD8 KLC4 NIN	7.12e-05	169	260	10	int:INSYN1
Interaction	RHOV interactions	USP9X NUP205 JUP DST MDN1 PI4KA CLTC ARHGEF6 IPO5 CSE1L MTOR PEAK1	7.97e-05	243	260	12	int:RHOV
Interaction	RAC1 interactions	CTNNAL1 USP9X EXOC3 GMIP NUP205 PHKG2 JUP DST MDN1 AP1B1 ARHGAP31 RALBP1 PI4KA CLTC UTRN METAP2 BAG6 ARHGEF6 ANK3 KIF26B GRIA2 ARHGAP1 CSE1L CEP89 MTOR NISCH FIBP MACF1 PEAK1	1.19e-04	1063	260	29	int:RAC1
Interaction	TNFSF13B interactions	MDN1 MAP3K15 RANBP2 GRAMD1A MAP3K6 IPO9 CSE1L MTOR	1.57e-04	119	260	8	int:TNFSF13B
Interaction	EBAG9 interactions	EXOC3 SLC30A2 JUP DST AP1B1 PI4KA RIC1 COG2 ANK3 COG7 TRAPPC8 ARHGAP1 PEAK1	1.66e-04	303	260	13	int:EBAG9
Interaction	LIN7B interactions	CLTCL1 MPDZ UTRN KIF26B PATJ	1.76e-04	41	260	5	int:LIN7B
GeneFamily	Ankyrin repeat domain containing	ACAP1 ANKRD49 ASAP2 MIB1 PLA2G6 TRPV3 ANKK1 ANKFY1 ANK3 NFKBIZ ANKRD50 FEM1B ASB2	5.68e-07	242	172	13	403
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	RGPD4 RGPD3 TTC38 NAA16 RGPD2 RANBP2 RGPD8 KLC4	1.42e-05	115	172	8	769
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	ZHX3 GAPVD1 AGO2 ERC1 USP9X BLM SLIT2 ASAP2 DST MDN1 ST3GAL5 GLRB UCK2 USP13 RANBP2 DMXL2 TUT4 TRIM2 CHD9 TRAPPC8 CSE1L SLC25A12 MACF1 AKAP11 BICRAL N4BP1 PLCE1	1.99e-07	856	265	27	M4500
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	RGPD4 USP9X RGPD3 RGPD2 RANBP2 RGPD8	8.89e-07	33	265	6	MM477
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	GAPVD1 AGO2 KIAA0232 POGZ DST TUT4 CPEB3 CHD9 ICE1 FEM1B BICRAL N4BP1 SMAD5	1.29e-05	300	265	13	M8702
Coexpression	GEORGES_TARGETS_OF_MIR192_AND_MIR215	ZBTB6 AGO2 ERMP1 SIX4 BLM PASK DST PXDN AGL MIB1 ASPM OTUD3 FBXO36 NFKBIZ RFC4 ZDHHC23 LRRCC1 SMARCB1 MACF1 AKAP11 BICRAL KDM1B PLCE1 NIN	1.45e-05	892	265	24	M18120
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	GLT1D1 USP9X NUP58 SIX4 NUP205 BLM PASK AUNIP MDN1 MAP3K15 UTF1 DDX4 NAA16 SESTD1 DMXL2 CCDC150 TRAPPC8 RFC4 XRCC5 PHC1 ZDHHC23 MTOR CAPRIN2 AKAP11 NLRP4 TXLNG	1.16e-05	822	262	26	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	USP9X ANKRD49 NUP58 BLM AUNIP MDN1 MAP3K15 UTF1 DDX4 NAA16 SESTD1 DMXL2 REXO5 CCDC150 TRAPPC8 RFC4 PAPOLG ZDHHC23 MTOR CARF CAPRIN2 AKAP11 KDM1B NLRP4 TXLNG	3.18e-05	820	262	25	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 MPDZ CFAP54 ASPM NAV2 DNAH5 DNAH6 TRIM2 ANK3 SYNE1 TACC2 MACF1	2.59e-09	196	266	12	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ABCA13 MPDZ CFAP54 ASPM NAV2 DNAH5 DNAH6 TRIM2 ANK3 SYNE1 TACC2 MACF1	2.59e-09	196	266	12	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	MPDZ ADGRV1 JUP NAV2 DNAH5 DNAH6 TRIM2 ANK3 SFTPD TACC2 PATJ	2.39e-08	192	266	11	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	NEK10 MPDZ CFAP54 NAV2 DNAH5 DNAH6 TRIM2 ANK3 SYNE1 TUSC3 TACC2	2.80e-08	195	266	11	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	NEK10 MPDZ CFAP54 NAV2 DNAH5 DNAH6 TRIM2 ANK3 SYNE1 TUSC3 TACC2	2.80e-08	195	266	11	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	CYBRD1 ABCA9 SVEP1 SLIT2 ASAP2 PXDN NAV2 SESTD1 COL6A3 CHD9 NFKBIZ	2.80e-08	195	266	11	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GRIPAP1 ERC1 FOCAD NOP9 MIB1 DMXL2 FBXO36 MAP3K6 LRRCC1 ASB2	1.89e-07	186	266	10	74eb69a52090f9e2426a47e03a1c478ee0cfec18
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CYBRD1 ABCA9 SVEP1 SLIT2 PXDN ST3GAL5 NAV2 SESTD1 COL6A3 CHD9	1.99e-07	187	266	10	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GRIPAP1 ERC1 FOCAD NOP9 MIB1 DMXL2 FBXO36 MAP3K6 LRRCC1 ASB2	1.99e-07	187	266	10	1eed2c1a05e80a7c8f639437c117afe0c18dfb0c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	JMY PASK UTRN TUT4 ANK3 GRAMD1A GPRIN3 MACF1 N4BP1 NIN	2.30e-07	190	266	10	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	CYBRD1 EPHA6 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 CHD9 NFKBIZ EYS	2.42e-07	191	266	10	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	NEK10 MPDZ CFAP54 NAV2 DNAH5 DNAH6 TRIM2 ANK3 TUSC3 TACC2	2.93e-07	195	266	10	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CTNNAL1 MPDZ ASAP2 DST UTRN TUT4 MACF1 SMAD1 SMAD5 NIN	3.70e-07	200	266	10	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ACAP1 JMY UTRN RANBP2 TUT4 SYNE1 GPRIN3 APOB MACF1	9.32e-07	171	266	9	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SIDT1 ADGRV1 USP44 NAV2 DNAH5 TRIM2 ANK3 EYS PATJ	1.18e-06	176	266	9	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTNNAL1 ERC1 ASAP2 SERPINB9 ARHGAP31 CLTC MIB1 IPO5 N4BP1	1.71e-06	184	266	9	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	PDE3A CYBRD1 SLIT2 COL6A3 ANK3 ADGRA2 SLC8A1 GUCY1B1 PLCE1	2.33e-06	191	266	9	78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MACF1 PEAK1	2.43e-06	192	266	9	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MACF1 PEAK1	2.43e-06	192	266	9	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	SVEP1 SLIT2 DST NAV2 COL6A3 KIF26B GRIK4 MACF1 PEAK1	2.43e-06	192	266	9	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	CYBRD1 EPHA6 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 CHD9 NFKBIZ	2.65e-06	194	266	9	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	CYBRD1 ABCA9 SVEP1 SLIT2 ASAP2 NAV2 SESTD1 COL6A3 CHD9	2.65e-06	194	266	9	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	CYBRD1 EPHA6 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 CHD9 NFKBIZ	2.76e-06	195	266	9	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBRD1 ADGRV1 NUP58 USP44 USP13 ANK3 SFTPD SYNE1 TACC2	2.88e-06	196	266	9	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	IPF-Epithelial\|IPF / Disease state, Lineage and Cell class	NEK10 CFAP54 NAV2 DNAH5 DNAH6 TRIM2 ANK3 TACC2 PATJ	2.88e-06	196	266	9	87d9881cfec461a5d89b688a83749b618c519485
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DMB SERPINB9 AP1B1 UTF1 GPRIN3 SLC8A1 CSF1R ASB2 CDH17	3.00e-06	197	266	9	515a2d0ee2bd3fc0a5a0c315e2b0c752e6af7406
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DMB SERPINB9 AP1B1 UTF1 GPRIN3 SLC8A1 CSF1R ASB2 CDH17	3.00e-06	197	266	9	bfa04e5f4156a01df4217b1f59676edb0a7563e1
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DMB SERPINB9 AP1B1 UTF1 GPRIN3 SLC8A1 CSF1R ASB2 CDH17	3.00e-06	197	266	9	4fccdc69ab4b966de6465f06677435e6f6e6abcd
ToppCell	AT2_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CYBRD1 NUP58 ST3GAL5 USP13 ANK3 SFTPD SYNE1 NFKBIZ TACC2	3.13e-06	198	266	9	8a1f984e46f4fa5be33027b9dbaa2ca060a2245d
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|World / disease group, cell group and cell class	ST3GAL5 DMXL2 NFKBIZ SLC8A1 CSF1R TLR4 KDM1B C9orf72 MARCO	3.13e-06	198	266	9	8449934e20bb2a34079fb642cae0d4647b9efe51
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	CTNNAL1 MPDZ DST TMEM150C TUT4 GPCPD1 MACF1 SMAD1 SMAD5	3.39e-06	200	266	9	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Papillary_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	GLRB PLA2G6 ODAD3 NPAS1 RBP3 GRIA2 METTL25B	5.94e-06	115	266	7	5f6f6a0f59f0f68aa20f9d98a15118176281ace6
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRV1 NAV2 DNAH5 TRIM2 ANK3 TACC2 TMEM132D PATJ	6.05e-06	162	266	8	5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB6 BLM GLRB SERPINF2 TTC38 TRIM2 CEP89 LRRCC1	6.93e-06	165	266	8	7c771f22b58989572c939ed127e637ec28dc0dca
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 BLM FOCAD ASPM RGPD2 DMXL2 LRRCC1 LY75	1.02e-05	174	266	8	58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 PDE3A CYP20A1 ABCA9 RANBP2 CHD9 SLC8A1 MACF1	1.11e-05	176	266	8	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NPY5R SYNE1 GPRIN3 ANKRD50 ADGRA2 GUCY1B1 PEAK1	1.36e-05	181	266	8	a2058d658f07ab6f0a28d2622f3090b4cde6f763
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 NPY5R SYNE1 GPRIN3 ANKRD50 ADGRA2 GUCY1B1 PEAK1	1.36e-05	181	266	8	526e858a848470b6d2d5248788004d9735ed3add
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A CYBRD1 ABCA9 SVEP1 SLIT2 DPEP3 NAV2 COL6A3	1.42e-05	182	266	8	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FKBP9 SVEP1 SLIT2 COL6A3 P3H3 OAT MACF1 PEAK1	1.42e-05	182	266	8	19c5e3a9d9b3728303b682102e276adfe93aa759
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A CYBRD1 ABCA9 SVEP1 SLIT2 DPEP3 NAV2 COL6A3	1.42e-05	182	266	8	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	390C-Lymphocytic-CD4_T-cell-Treg_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	GRIPAP1 FOCAD NOP9 MIB1 DMXL2 FBXO36 LRRCC1 ASB2	1.47e-05	183	266	8	228092290dbb08785c4eda224e3ad03e99e10fab
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A CPT1B SLC8A1 GUCY1B1 KDM1B ASB2 GDF11 PLCE1	1.47e-05	183	266	8	421265fa15d5a028cb567bb0904e670473ef102b
ToppCell	facs-Heart-LA-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A CPT1B SLC8A1 GUCY1B1 KDM1B ASB2 GDF11 PLCE1	1.47e-05	183	266	8	8d45dff06a199b1369576657f7f9dc0249c5f841
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 ADGRV1 DNAH5 KIF26B MROH2A APOB SLC8A1 PLCE1	1.53e-05	184	266	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 ADGRV1 DNAH5 KIF26B MROH2A APOB SLC8A1 PLCE1	1.53e-05	184	266	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 ADGRV1 DNAH5 KIF26B MROH2A APOB SLC8A1 PLCE1	1.53e-05	184	266	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	RV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	EPHA6 ABCA9 SVEP1 KCNJ13 RGPD2 COL6A3 CDH17	1.62e-05	134	266	7	8c4046ba1f85172915a112499e492c3efe8474c2
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 GRIK4 MACF1	1.72e-05	187	266	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ABCA9 SVEP1 PXDN NAV2 COL6A3 NPY5R ADGRA2	1.86e-05	189	266	8	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A ABCA9 SVEP1 PXDN NAV2 COL6A3 NPY5R ADGRA2	1.86e-05	189	266	8	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TRABD2B FKBP9 SLIT2 NAV2 COL6A3 NFKBIZ MACF1 PEAK1	1.86e-05	189	266	8	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	TRABD2B FKBP9 SLIT2 NAV2 SLITRK6 COL6A3 MACF1 PEAK1	1.93e-05	190	266	8	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP9X FKBP9 ABCA9 AP1B1 CLTC SLC8A1 CSF1R NISCH	1.93e-05	190	266	8	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	EPHA6 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 CHD9 NFKBIZ	1.93e-05	190	266	8	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 GRIK4 MACF1	2.00e-05	191	266	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	COVID-19-kidney-CNT\|kidney / Disease (COVID-19 only), tissue and cell type	TRABD2B ERMP1 ASAP2 RALBP1 METAP2 MXRA5 NFKBIZ SLC8A1	2.08e-05	192	266	8	d32ae226d95b4b6adb99d14b602be09b661d4cd9
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	CYBRD1 EPHA6 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 NFKBIZ	2.08e-05	192	266	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 GRIK4 MACF1	2.08e-05	192	266	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP9X ADGRV1 ZXDA CLTC UTRN RANBP2 ANKRD50 KDM1B	2.16e-05	193	266	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 GRIK4 MACF1	2.16e-05	193	266	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	CYBRD1 ABCA9 SVEP1 SLIT2 SESTD1 COL6A3 CHD9 NFKBIZ	2.16e-05	193	266	8	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ABCA9 SVEP1 SLIT2 DST COL6A3 MXRA5 KIF26B MTHFD1L	2.24e-05	194	266	8	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A CYBRD1 ABCA9 SVEP1 PXDN NAV2 COL6A3 ADGRA2	2.24e-05	194	266	8	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRABD2B SVEP1 SLIT2 DST COL6A3 KIF26B GRIK4 PLCE1	2.24e-05	194	266	8	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTNNAL1 ERC1 ASAP2 DST ARHGAP31 GRIK4 MACF1 SMAD1	2.24e-05	194	266	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A CYBRD1 ABCA9 SVEP1 PXDN NAV2 COL6A3 ADGRA2	2.24e-05	194	266	8	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 NISCH MACF1 PEAK1	2.33e-05	195	266	8	b616ee6f1d878935d293c8e0a8bbc5b4385301f0
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	1c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CYBRD1 HLA-DMB ABCA9 AP1B1 NAV2 SYNE1 CSF1R NISCH	2.33e-05	195	266	8	4008fa86b5166087a4b20f89ae07e1dfc87c855d
ToppCell	PND10-Mesenchymal-Mesenchymal_structural\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	11d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 KIF26B GRIK4	2.33e-05	195	266	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ABCA9 SVEP1 SLIT2 NAV2 SESTD1 COL6A3 MTHFD1L CHD9	2.33e-05	195	266	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	1f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCell	PND07-Mesenchymal-Mesenchymal_structural\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 NISCH MACF1 PEAK1	2.33e-05	195	266	8	2f9a274b26fc528a85f50933ec2f4db1dc9da0ca
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADGRV1 NAV2 DNAH5 ANK3 SFTPD SYNE1 TACC2 PATJ	2.33e-05	195	266	8	9406866f99555198a9be311fbd65751b70f35446
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TRABD2B FKBP9 SVEP1 SLIT2 SLITRK6 COL6A3 MACF1 PEAK1	2.33e-05	195	266	8	10f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	ADGRV1 NAV2 DNAH5 ANK3 SFTPD SYNE1 TACC2 PATJ	2.33e-05	195	266	8	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|COVID-19_Moderate / disease group, cell group and cell class	DMXL2 NFKBIZ SLC8A1 CSF1R TLR4 KDM1B C9orf72 MARCO	2.41e-05	196	266	8	256c557fa11414c9d2cbb1fcff33f482ee1c78ac
ToppCell	E17.5-Mesenchymal\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FKBP9 SVEP1 SLIT2 COL6A3 P3H3 GUCY1B1 MACF1 PEAK1	2.41e-05	196	266	8	b4ee991445b612506372b9361ebfe72cb59b811e
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DMB DMXL2 GPRIN3 SLC8A1 CSF1R TLR4 GPCPD1 MARCO	2.41e-05	196	266	8	5fe6534af65d43eeacd4b031310242b4f706008b
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ZHX3 ZBTB6 COL6A3 DMXL2 MXRA5 PCDHB2 LRRCC1 CDH17	2.50e-05	197	266	8	4edf043e8f586fd375f56485841fe992a18bf853
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	SVEP1 SLIT2 SLITRK6 UTRN COL6A3 SFTPD SYNE1 CHD9	2.50e-05	197	266	8	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SVEP1 SLIT2 DST BSN COL6A3 MXRA5 SYNE1 MACF1	2.50e-05	197	266	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRABD2B SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MXRA5 TUSC3	2.50e-05	197	266	8	5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRABD2B SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MXRA5 TUSC3	2.50e-05	197	266	8	b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-DMB AP1B1 UTRN DMXL2 GPRIN3 SLC8A1 CSF1R TLR4	2.50e-05	197	266	8	10190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell	10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRABD2B SVEP1 SLIT2 NAV2 TMEM150C COL6A3 MXRA5 TUSC3	2.50e-05	197	266	8	1baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	ABCA13 NEK10 DNAH5 DNAH6 STOML3 TRIM2 TUSC3 TACC2	2.50e-05	197	266	8	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	ASK428-Epithelial-Type_1\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	CEACAM5 CYBRD1 DST NAV2 SESTD1 LAMA5 N4BP1 PLCE1	2.50e-05	197	266	8	9ae6661c307791c3f0ecd3d378e3d917565e5498
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	HLA-DMB GMIP SERPINB9 GPRIN3 SLC8A1 CSF1R ASB2 CDH17	2.50e-05	197	266	8	7e15ed71881105dee5c7ffc052063ecc8ac0b36e
ToppCell	COVID-19-Myeloid\|COVID-19 / group, cell type (main and fine annotations)	HLA-DMB DMXL2 SLC8A1 CSF1R TLR4 GPCPD1 C9orf72 MARCO	2.59e-05	198	266	8	33f0a919188a67d2a876b52c61a1cec2c9747969
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 KIF26B GRIK4	2.59e-05	198	266	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SIDT1 EDC4 UTRN TTC38 COL6A3 SYNE1 MACF1 N4BP1	2.59e-05	198	266	8	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABCA9 SVEP1 SLIT2 DST NAV2 COL6A3 KIF26B GRIK4	2.59e-05	198	266	8	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DMB SPNS3 DST UCK2 SERPINF2 UTF1 SLC8A1 CSF1R	2.59e-05	198	266	8	d0371e2ca9e25727b35985940f6228f9d8e49727
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADGRV1 USP44 ST3GAL5 NAV2 ANK3 SFTPD CAT PATJ	2.59e-05	198	266	8	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	Sigmoid-(1)_T_cell-(14)_Tcm\|Sigmoid / shred on region, Cell_type, and subtype	SLC30A2 PASK RGPD3 PLA2G6 RGPD8 SYNE1 GPRIN3 MTOR	2.69e-05	199	266	8	ec454fa22fb7f50a947bdf4c4bb6f0ba13f62b4c
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	ST3GAL5 UROD UTRN ANKFY1 TRIM2 NUMA1 OPA3 ARHGAP1 GTF2A1 METTL25B CSE1L CWF19L1 SMAD5	4.31e-07	192	265	13	4746_DN
Drug	isocoproporphyrin	CLTC UROD BRD2	1.56e-06	3	265	3	CID000169785
Disease	Kartagener syndrome (implicated_via_orthology)	SLIT2 AP1B1 DNAH5 ODAD3	5.25e-06	14	257	4	DOID:0050144 (implicated_via_orthology)
Disease	primary ciliary dyskinesia (implicated_via_orthology)	SLIT2 AP1B1 DNAH5 ODAD3	1.97e-05	19	257	4	DOID:9562 (implicated_via_orthology)
Disease	Nonorganic psychosis	PLA2G6 NPAS1 ANK3 GRIK4 C9orf72 CDH17	3.12e-05	69	257	6	C0349204
Disease	Metastatic melanoma	NEK10 PASK MAP3K15 MTOR PEAK1	1.08e-04	54	257	5	C0278883
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	GAPVD1 NUP205 ANKFY1 PLCE1	1.29e-04	30	257	4	C1868672
Disease	urate measurement, spine bone mineral density	NAV2 RIC1 UGT1A1 SLC8A1 CEP89	1.52e-04	58	257	5	EFO_0004531, EFO_0007701
Disease	probable RNA-binding protein EIF1AD measurement	NLRP12 EIF1AD	2.25e-04	3	257	2	EFO_0801918
Disease	Psychotic Disorders	PLA2G6 NPAS1 ANK3 GRIK4 C9orf72 CDH17	2.62e-04	101	257	6	C0033975
Disease	preeclampsia, hypertension, pregnancy-induced	ZNF831 NPRL3 PLCE1	3.36e-04	16	257	3	EFO_0000668, MONDO_0024664
Disease	autosomal dominant polycystic kidney disease (is_implicated_in)	PKD1 MTOR	4.48e-04	4	257	2	DOID:898 (is_implicated_in)
Disease	arthrogryposis multiplex congenita (is_implicated_in)	MYH8 SYNE1	4.48e-04	4	257	2	DOID:0080954 (is_implicated_in)
Disease	protein-tyrosine kinase 2-beta measurement	NLRP12 APOB	4.48e-04	4	257	2	EFO_0801969
Disease	cancer (implicated_via_orthology)	ACAP1 JUP DST IPO5 PHC1 CSF1R MTOR SMARCC2 MACF1	6.10e-04	268	257	9	DOID:162 (implicated_via_orthology)
Disease	Partial Fetal Alcohol Syndrome	ANK3 CAT	7.43e-04	5	257	2	C3661483
Disease	hypertension, pregnancy-induced	ZNF831 PLCE1	7.43e-04	5	257	2	MONDO_0024664
Disease	Alcohol Related Neurodevelopmental Disorder	ANK3 CAT	7.43e-04	5	257	2	C0814154
Disease	systolic blood pressure, alcohol drinking	PDE3A NEK10 ZNF831 EYS GUCY1B1 NPRL3	9.21e-04	128	257	6	EFO_0004329, EFO_0006335
Disease	amphetamine abuse (implicated_via_orthology)	MAP3K15 MAP3K6	1.11e-03	6	257	2	DOID:670 (implicated_via_orthology)
Disease	crescentic glomerulonephritis (implicated_via_orthology)	CSF1R MTOR	1.11e-03	6	257	2	DOID:13139 (implicated_via_orthology)
Disease	nischarin measurement	NLRP12 NISCH	1.11e-03	6	257	2	EFO_0801841
Disease	Alcohol Related Birth Defect	ANK3 CAT	1.11e-03	6	257	2	C3146244
Disease	Inflammatory Myofibroblastic Tumor	CLTC RANBP2	1.11e-03	6	257	2	C0334121
Disease	Behcet Syndrome	CAT APOB TLR4	1.15e-03	24	257	3	C0004943
Disease	daytime rest measurement	ZHX3 SPTB BLM FOCAD STOML3 KIF26B TLR4 FSHR PATJ	1.20e-03	295	257	9	EFO_0007828
Disease	newborn respiratory distress syndrome (is_implicated_in)	SFTPD CAT	1.54e-03	7	257	2	DOID:12716 (is_implicated_in)
Disease	hypertension	PDE3A ZNF831 ARHGAP31 BAG6 COL6A3 MKNK1 GUCY1B1 NPRL3 PLCE1	1.58e-03	307	257	9	EFO_0000537
Disease	cortical surface area measurement	ZHX3 PDE3A SIDT1 CUL9 SLC12A8 ADGRV1 SVEP1 FOCAD SLIT2 ARHGAP31 RALBP1 PKD1 NAV2 METAP2 TRIM2 ANK3 KIF26B ADGRA2 ARHGAP1 FSHR MACF1 SMAD5 PLCE1	1.68e-03	1345	257	23	EFO_0010736
Disease	mean arterial pressure, alcohol drinking	NEK10 ZNF831 CLCN6 ICE1 NPRL3	1.69e-03	98	257	5	EFO_0004329, EFO_0006340
Disease	serum metabolite measurement	PDE3A EPHA6 GLT1D1 ERMP1 NUP58 SLIT2 SLC7A6OS RIC1 KIF26B CAT APOB GRIK4 UGT1A1 CSF1R CEP89 FSHR NPRL3 TTL	1.70e-03	945	257	18	EFO_0005653
Disease	coronary artery disease	ZHX3 CLTCL1 SPNS3 ZNF831 SVEP1 ASAP2 KCNJ13 BSN COL6A3 MTHFD1L PPHLN1 APOB GRIK4 ANKRD50 GUCY1B1 TMEM132D CARF NPRL3 NLRP4 CDH17 PLCE1	1.90e-03	1194	257	21	EFO_0001645
Disease	lean body mass	PDE3A CYBRD1 ADGRV1 RALBP1 SLC25A23 IPO9 FSHR NPRL3 PATJ PLCE1	1.92e-03	379	257	10	EFO_0004995
Disease	Intellectual Disability	PEX6 POGZ AP1B1 ST3GAL5 SYNE1 COQ5 GRIA2 ZDHHC9 MTOR SMARCC2 MACF1	2.01e-03	447	257	11	C3714756
Disease	male homosexuality	SLITRK6 SLC8A1	2.04e-03	8	257	2	EFO_0008486
Disease	retinal vasculature measurement	PDE3A PXDN SERPINF2 DNAH5 METAP2 IPO5 LRIT2 EYS CSE1L TMEM132D PATJ PLCE1	2.07e-03	517	257	12	EFO_0010554
Disease	Tonic - clonic seizures	MPDZ MIB1 GRIA2 CAT SLC8A1	2.20e-03	104	257	5	C0494475
Disease	Seizures, Focal	MPDZ MIB1 GRIA2 CAT SLC8A1	2.20e-03	104	257	5	C0751495
Disease	Myoclonic Seizures	MPDZ MIB1 GRIA2 CAT SLC8A1	2.20e-03	104	257	5	C4317123
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC2 BICRAL	2.61e-03	9	257	2	DOID:1925 (implicated_via_orthology)
Disease	Carcinoma, Small Cell	UGT1A1 MTOR	2.61e-03	9	257	2	C0262584
Disease	Disorder of eye	ADGRV1 KCNJ13 RBP3 OPA3 OAT EYS CNGB3	2.67e-03	212	257	7	C0015397
Disease	mean arterial pressure, unipolar depression	ZNF831 CLCN6 NPRL3	2.69e-03	32	257	3	EFO_0003761, EFO_0006340
Disease	Squamous cell carcinoma of lung	MAP3K15 ANKK1 CSF1R	2.69e-03	32	257	3	C0149782
Disease	Grand Mal Status Epilepticus	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0311335
Disease	Petit mal status	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0270823
Disease	Complex Partial Status Epilepticus	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0393734
Disease	Status Epilepticus, Subclinical	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0751522
Disease	Simple Partial Status Epilepticus	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0751524
Disease	Non-Convulsive Status Epilepticus	ANK3 GRIA2 CAT SLC8A1	2.80e-03	67	257	4	C0751523
Disease	Status Epilepticus	ANK3 GRIA2 CAT SLC8A1	2.96e-03	68	257	4	C0038220
Disease	cutaneous leishmaniasis (is_marker_for)	CAT TLR4	3.25e-03	10	257	2	DOID:9111 (is_marker_for)
Disease	cystic kidney disease (implicated_via_orthology)	SLIT2 LAMA5	3.25e-03	10	257	2	DOID:2975 (implicated_via_orthology)
Disease	respiratory syncytial virus infectious disease (is_implicated_in)	SFTPD TLR4	3.25e-03	10	257	2	DOID:1273 (is_implicated_in)
Disease	lung disease (biomarker_via_orthology)	SFTPD CAT TLR4	3.48e-03	35	257	3	DOID:850 (biomarker_via_orthology)
Disease	diastolic blood pressure, alcohol drinking	NEK10 ZNF831 CLCN6 GUCY1B1 NPRL3	3.80e-03	118	257	5	EFO_0004329, EFO_0006336
Disease	gastric adenocarcinoma (is_implicated_in)	ABCA13 PLCE1	3.95e-03	11	257	2	DOID:3717 (is_implicated_in)
Disease	insomnia, bilirubin measurement	MROH2A UGT1A1	3.95e-03	11	257	2	EFO_0004570, EFO_0004698
Disease	atopic dermatitis (implicated_via_orthology)	TRPV3 NFKBIZ	3.95e-03	11	257	2	DOID:3310 (implicated_via_orthology)
Disease	Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement	FOCAD ANK3	3.95e-03	11	257	2	EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175
Disease	visceral heterotaxy (implicated_via_orthology)	SLIT2 AP1B1 DNAH5	4.08e-03	37	257	3	DOID:0050545 (implicated_via_orthology)
Disease	non-high density lipoprotein cholesterol measurement	ZHX3 PEX6 ABCA9 PLA2G6 TRIM2 APOB MAP3K6 PHC1 UGT1A1 CSE1L CSF1R GPCPD1 CWF19L1 PLCE1	4.16e-03	713	257	14	EFO_0005689
Disease	ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis	ZNF831 LDHD ASAP2 OTUD3 BSN TLR4 FIBP RAVER1	4.53e-03	295	257	8	EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268
Disease	thioredoxin domain-containing protein 12 measurement	FYCO1 BSN TUT4	4.74e-03	39	257	3	EFO_0008298
Disease	preeclampsia	ZNF831 CLCN6 NPRL3 PLCE1	4.84e-03	78	257	4	EFO_0000668
Disease	Cocaine Abuse	AGO2 ANKK1 GRIA2 SMAD1 SMAD5	5.18e-03	127	257	5	C0009171
Disease	small cell lung carcinoma	SPNS3 ADGRV1 BAG6 PHC1	5.30e-03	80	257	4	EFO_0000702
Disease	Malignant Neoplasms	BLM CAT UGT1A1 CSF1R MTOR	5.35e-03	128	257	5	C0006826
Disease	lung disease (implicated_via_orthology)	CAT TLR4	5.53e-03	13	257	2	DOID:850 (implicated_via_orthology)
Disease	Neurodegeneration with brain iron accumulation	DCAF17 PLA2G6	5.53e-03	13	257	2	cv:C2931845
Disease	juvenile polyposis syndrome (implicated_via_orthology)	SMAD1 SMAD5	5.53e-03	13	257	2	DOID:0050787 (implicated_via_orthology)
Disease	Coffin-Siris syndrome	SMARCB1 SMARCC2	5.53e-03	13	257	2	C0265338
Disease	Fetal Alcohol Spectrum Disorders	ANK3 CAT	5.53e-03	13	257	2	C2985290
Disease	white matter integrity	TRABD2B CTNNAL1 AGL BAG6 CARF	5.71e-03	130	257	5	EFO_0004641
Disease	vital capacity	PDE3A ERC1 SIX4 JMY SVEP1 DST UTRN METAP2 ARHGEF6 COL6A3 SYNE1 GPRIN3 APOB SLC8A1 CSE1L CAPRIN2 PATJ NLRP4 MARCO PLCE1	6.08e-03	1236	257	20	EFO_0004312
Disease	severe acute respiratory syndrome, COVID-19	USP9X PXDN COL6A3 MXRA5 P3H3 SFTPD MTHFD1L EYS PATJ TUBD1	6.13e-03	447	257	10	EFO_0000694, MONDO_0100096
Disease	carotid artery intima media thickness	PDE3A AGL NAV2 ANKK1 MTHFD1L GRIA2 APOB TACC2 SLC8A1 CDH17	6.41e-03	450	257	10	EFO_0007117
Disease	tetralogy of Fallot (implicated_via_orthology)	DNAH5 PHC1	6.42e-03	14	257	2	DOID:6419 (implicated_via_orthology)
Disease	Diabetic Neuralgia	CAT TLR4	6.42e-03	14	257	2	C0751074
Disease	Diabetic Neuropathies	CAT TLR4	6.42e-03	14	257	2	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	CAT TLR4	6.42e-03	14	257	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	CAT TLR4	6.42e-03	14	257	2	C0271673
Disease	Diabetic Mononeuropathy	CAT TLR4	6.42e-03	14	257	2	C0271678
Disease	Diabetic Autonomic Neuropathy	CAT TLR4	6.42e-03	14	257	2	C0271686
Disease	Diabetic Amyotrophy	CAT TLR4	6.42e-03	14	257	2	C0271685
Disease	Diabetic Polyneuropathies	CAT TLR4	6.42e-03	14	257	2	C0271680
Disease	Diabetic Asymmetric Polyneuropathy	CAT TLR4	6.42e-03	14	257	2	C0393835
Disease	response to selective serotonin reuptake inhibitor, openness measurement	UTRN TUSC3	6.42e-03	14	257	2	EFO_0005658, EFO_0007914
Disease	Malignant neoplasm of breast	ACAP1 CTU2 SIX4 NOP9 PCDHGB6 SYNE1 TP53I3 PPHLN1 CAT TACC2 TRAPPC8 RFC4 MAP3K6 GTF2A1 CSF1R MTOR NISCH MACF1	6.43e-03	1074	257	18	C0006142
Disease	Autosomal recessive primary microcephaly	ASPM PHC1	7.36e-03	15	257	2	cv:C3711387
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	AKR1E2 SLITRK6 KIF26B TACC2	7.40e-03	88	257	4	EFO_0803332
Disease	Cocaine Dependence	AGO2 ANKK1 GRIA2 SMAD1 SMAD5	7.53e-03	139	257	5	C0600427
Disease	proliferative diabetic retinopathy (is_marker_for)	SLIT2 CAT	8.37e-03	16	257	2	DOID:13207 (is_marker_for)
Disease	vision disorder	TRABD2B PXDN	8.37e-03	16	257	2	MONDO_0021084
Disease	response to triptolide, cytotoxicity measurement	NEK10 ADGRA2	8.37e-03	16	257	2	EFO_0006952, EFO_0007662
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	PKD1 MTOR	8.37e-03	16	257	2	DOID:0110861 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
RISINQALQHAFIQE	PRPF4B	991	Q13523
FAQLAENIASSLHVA	ERV3-1	276	Q14264
VIQHIEALANFTQRA	ERVPABLB-1	341	P60509
SQHQISEDFVILANR	DCAF17	376	Q5H9S7
TNLQDIIHLLEGNEF	CFAP54	2456	Q96N23
QQAHQLAFDSVFLRI	COG7	576	P83436
AVNVLTQHSDELEQF	ARHGEF6	341	Q15052
AHEALQDASVLIFAN	ARL5C	111	A6NH57
LAIISVVAVFENHNV	CYBRD1	96	Q53TN4
ARGLDIENVQHVINF	DDX4	601	Q9NQI0
ENIAGHLKDAQIFIQ	CAT	461	P04040
DTVLLLLNAIHFQGF	SERPINF2	226	P08697
FLQEQFNSIAAHVLH	BAG6	841	P46379
AQHISVNARNVALEA	ADGRA2	531	Q96PE1
NNNVYATELLLQHGA	ASB2	421	Q96Q27
FQAAINAAIIEIATN	ABCA9	181	Q8IUA7
HLAAQNNFENVARLL	ANKK1	466	Q8NFD2
IDGNIQQHTQELFIS	CEACAM5	451	P06731
DAFLQNGAHFLVQLE	ADGRV1	601	Q8WXG9
NGAHFLVQLETVELL	ADGRV1	606	Q8WXG9
HGQNLSFINISIIDD	ADGRV1	4461	Q8WXG9
LRNAIAQNLHFVQEV	ABCA13	451	Q86UQ4
LSAIQGVTLAQDHFQ	ABCA13	2971	Q86UQ4
LQQDEHANLTEVTFL	AKAP11	46	Q9UKA4
FVLRLVEAQATHFQQ	ACAP1	191	Q15027
EGFHDESTQVQLQLL	AP1B1	471	Q10567
EAQEFALHLINSNLQ	ANKRD50	451	Q9ULJ7
NTQLLHVFQEDFIIG	DMXL2	846	Q8TDJ6
LVQALTAHLNVNSFA	MTHFD1L	436	Q6UB35
HAVIFLFNGAEENVL	ERMP1	241	Q7Z2K6
FVNNSHGANNELELV	ASPM	321	Q8IZT6
LINSVFHVGAERLQQ	GRAMD1A	371	Q96CP6
VSEGQFQQVLHHELL	AGO2	671	Q9UKV8
VDNLLAAAVVQEHSN	C18orf25	261	Q96B23
AANVAHGLQQNVLYV	RAD51D	121	O75771
LNGEQAEAAINAFHQ	RAVER1	101	Q8IY67
FTHVQELFGNVVLKQ	RALBP1	361	Q15311
HITFAILDAVNGNIE	RANBP2	651	P49792
LQEFANAILQQIADH	ERC1	1086	Q8IUD2
LTAFQLLHLVGNVQA	TP53I3	126	Q53FA7
HITFAILDAVNGNIE	RGPD8	651	O14715
RQHATLLFNTALEQG	RIC1	956	Q4ADV7
HLNQAFQQALTAADL	EDC4	1276	Q6P2E9
LDVVLQTFHLAGVQD	HDHD3	76	Q9BSH5
HAQVGNLSQAIENVL	P3H3	326	Q8IVL6
LIHNVQRDFIIQTGD	PPIL4	41	Q8WUA2
GLAIVSQHDLDQLQA	NUP205	1951	Q92621
AHTVNFVLQAQAEAS	NOX5	331	Q96PH1
HILQSLDGFVFALNQ	NPAS1	141	Q99742
ATATLHLVFADNLQE	PCDHGB6	656	Q9Y5F9
VSINADNGHLFALQS	PCDHB2	506	Q9Y5E7
ALNLDGQHLFEITNL	LRRC9	891	Q6ZRR7
QIFFTNVIQALGEHL	CCNC	41	P24863
GRNFLHVAVQNSDIE	ANKFY1	871	Q9P2R3
QGLEALRSEHQAVLQ	KLC4	31	Q9NSK0
SSEIFQVNGHNRLLV	OVOS1	1056	Q6IE37
RVHLAQIQIEGDFLQ	DDI1	301	Q8WTU0
QVVAGAQALQLFESH	UROD	206	P06132
SLFEEHLQGQLQTLA	NOP9	346	Q86U38
HANIIKVLDIFENQG	PASK	1061	Q96RG2
AQIQAQIGALEEQLH	KRT28	346	Q7Z3Y7
ANFVDVIHTNAARIL	PNLIPRP3	211	Q17RR3
NQAEGHESNFIAQLA	MDN1	5071	Q9NU22
QSAFQVAVAANQHLI	NFKBIZ	481	Q9BYH8
LDNQRSAQFEHTVLI	METAP1D	306	Q6UB28
HLLNVINENFGTLAF	METAP2	401	P50579
IAQNEENDFLAIGLH	EYS	3021	Q5T1H1
GLFSFQDLRAVHQQL	JMY	231	Q8N9B5
FSNLQSAIDILHSQV	ERVS71-1	481	P61550
LNFNNISVIHLGALE	LRIT2	86	A6NDA9
NNLHEVETAQGQRFL	EIF1AD	36	Q8N9N8
LLDSGHQAQLVEFLI	GMIP	736	Q9P107
LTQTENRLIGHQEAF	DST	3656	Q03001
LALSQAQLEVHQGEV	FYCO1	771	Q9BQS8
LHIVDFLVQNSGNLD	ASAP2	601	O43150
GNILNSVAIQAHQYL	KIF26B	301	Q2KJY2
ALQLLEHEQATTQDN	GAPVD1	611	Q14C86
INLNAQEHTFLATAT	BSN	1716	Q9UPA5
QTLSAEQFHLVDQNG	CARF	71	Q8N187
HQDLVQDILLNVSFF	C1orf109	186	Q9NX04
NAVDNEGNSALHIIV	FEM1B	526	Q9UK73
IILQENAQHATRFIA	CWF19L1	211	Q69YN2
INAAVLLIAAGQHFE	MAP3K6	396	O95382
HIDNLEVANSFAVTN	GRIA2	61	P42262
ALQETHQQTLDDLQA	MYH8	1001	P13535
QLLHILQGDRNFVSD	NEK10	336	Q6ZWH5
TVLNSHLLAGNQELF	KIAA0232	621	Q92628
VGHLALALEALQAQV	OPA3	126	Q9H6K4
QLANLQESFISHIVG	PDE3A	996	Q14432
AVRQSLAVHFNIQQD	PEAK1	1376	Q9H792
AEDFGQALEQLQTAH	PEX6	676	Q13608
NLVADNIDTHLLAFE	NAA16	666	Q6N069
DADLALLQVFQLAAH	NPRL3	301	Q12980
FLENSHLQGQTALIF	FBXO36	61	Q8NEA4
IHINGQSIDNFQISE	KCNJ13	341	O60928
NALANIAANIQDEHL	PI4KA	711	P42356
SVHNQNGQLFLEDIV	LY75	1431	O60449
ANFHDVTQENILLFI	GLRB	151	P48167
AFSLNGVELLHLNNV	HM13	191	Q8TCT9
GSNVREFLQNLDALH	GUCY1B1	91	Q02153
NLLQEANFHIIDNVD	NLRP4	571	Q96MN2
LQAHVAQENRVVAFF	METTL25B	396	Q96FB5
VASFLLQHDADINAQ	ANKRD49	156	Q8WVL7
EAAEAHAQQLGQLAL	LAMA5	2486	O15230
ATAAFILANEHNVAL	IPO5	196	O00410
QNSGVEALIHAILRA	JUP	431	P14923
SLLEAVSFLHANNIV	PHKG2	136	P15735
NILRISESGFQHLEN	LRRC70	191	Q7Z2Q7
LEQTAAQVDALQGHL	MACF1	3586	Q9UPN3
ASQLLHQAEVAQQEF	MACF1	5091	Q9UPN3
LQQAQGFHSEIEDFL	MACF1	6331	Q9UPN3
EVAELLVHQGNANLD	MIB1	646	Q86YT6
NDAIVAFARNHQLNV	OTUD3	136	Q5T2D3
QASLVFDVALLDLHN	FKBP9	241	O95302
VGNLERNEFITLAHV	PAPOLG	401	Q9BWT3
AHVTFAILDAVNGNI	RGPD3	651	A6NKT7
ALADFIHQQRTQQVE	EXOSC10	236	Q01780
NFVASHIANILNSEE	APOB	591	P04114
NGFSSLEENLLHQVE	CHD9	381	Q3L8U1
FGVLNSLANVLSQHL	HLA-DMB	66	P28068
QESAILQLFHQDGTF	CLCN6	446	P51797
LTLNLDQVDFQHAGN	CSF1R	261	P07333
LSQLHVFDFGQEIQD	DNAH6	996	Q9C0G6
HVFNENGNLEVLVQS	ICE1	296	Q9Y2F5
HVILEQYQANVGAAL	HEATR5B	1336	Q9P2D3
QFENLLGINVHTEDL	GPCPD1	551	Q9NPB8
IQFSELEGQVLQFHL	KDM1B	526	Q8NB78
HNFRTNQLEAINAAL	BLM	666	P54132
GAFILQQLQRDQAHT	BICRAL	701	Q6AI39
TQTFQEQNLLLDAAH	CCDC150	386	Q8NCX0
QDLIHQLEVFAAEGL	CTNNAL1	621	Q9UBT7
AAISARFVQLQHNDI	CPEB3	606	Q8NE35
SEINQSADNLHIFLL	GLT1D1	156	Q96MS3
AHQYLANLVGLAENI	CEP89	601	Q96ST8
LEFHGSQQALEEQLQ	LDHD	326	Q86WU2
HGISLNEAQEVLARN	C9orf153	46	Q5TBE3
NIGLALDFVVENHFT	COL6A3	321	P12111
SLQAEGFNNHVLSVR	CRYBG2	1466	Q8N1P7
QQILDLHDFQGDALQ	GDF11	111	O95390
RESGNQNIFLHIVDL	DHRS12	86	A0PJE2
LQQGHDQVVSLLLEN	ANK3	181	Q12955
ASNHAILQLFQGDQI	CAPRIN2	1086	Q6IMN6
ELLSETQQAAFHQIA	MARCO	11	Q9UEW3
AFGIRNVTHIDQALQ	COQ5	216	Q5HYK3
AAQDLLLAVATDFQN	IPO9	401	Q96P70
QERLLAILQHSAQDF	CUL9	2416	Q8IWT3
AILQHSAQDFRVGLQ	CUL9	2421	Q8IWT3
VLNFESGHDINVIQA	DCAF8L1	231	A6NGE4
VGVALRLANNSEHIN	DCLRE1A	271	Q6PJP8
ERIATEFNQLQFHAV	COG2	171	Q14746
NFSQHIFIDSLVQGN	CYP20A1	246	Q6UW02
VLQDVNLRNFSHGQT	DPEP3	111	Q9H4B8
IQDNINIHTIERNSF	FSHR	151	P23945
HSQLAAAVENLKNIF	EXOC3	106	O60645
DRVNILGFSIFNQSH	GRIK4	261	Q16099
DAESLGIAIQNHLQR	GPRIN3	701	Q6ZVF9
HAAALRALQDQVSIQ	GRIPAP1	306	Q4V328
THNLQVAALDANGII	CDH17	91	Q12864
QVQELFHEAAQQDAL	SLC12A8	6	A0AV02
QFALRQNLHEIESAG	PPHLN1	331	Q8NEY8
EDALLHLAQQNEQAV	CNTD1	26	Q8N815
AAVDSFLQQQHVLGA	CTU2	176	Q2VPK5
QLFTEDSQGQRVIAH	AUNIP	286	Q9H7T9
LLFTQDSEGNQVIRH	AUNIP	341	Q9H7T9
FLANHTLNGEILRNA	C9orf72	61	Q96LT7
NTDVQAARLGNIIHA	CPT1B	266	Q92523
EAIQTSHFQGRLNEV	FOCAD	1296	Q5VW36
HLVIRQAAANIQETG	DNAH5	1801	Q8TE73
EAFAQHVLNRAQDIT	TBRG4	351	Q969Z0
QHLASLQIFIAEGNN	LRRC30	206	A6NM36
HTVDDIQQIAAALAQ	PKD1	2656	P98161
FVALAAQLQSIHENV	NUP58	396	Q9BVL2
QRVEFATLQEALAHA	NUMA1	1041	Q14980
INNSVIVLDFVSHVN	EPHA6	396	Q9UF33
FAAEAIALNRQLSQH	MKNK1	401	Q9BUB5
HLAQAENLQALFVAL	MTOR	686	P42345
LELHDSGTFQQVVNL	MROH2A	26	A6NES4
VDNIQQHFLLSDRLA	FIBP	156	O43427
SQIHLVLFGFQDAVN	MAP3K15	1086	Q6ZN16
ILHDRFINGSALNVQ	USP9X	236	Q93008
QNQLEIFDGNVAHIS	UTRN	1651	P46939
LIDEGHAATQLVNQL	RFC4	296	P35249
AHVTFAILDAVNGNI	RGPD4	651	Q7Z3J3
EIQAFGHRLQENFSL	MRPL44	71	Q9H9J2
LHNVTNFLIGNLALS	PRLHR	91	P49683
ISIHLGFNNIADIEI	SLITRK6	91	Q9H5Y7
NQLGHIFTNDEDVIA	SLC47A2	391	Q86VL8
RINFLQSVVAEHQQF	SYNE1	1756	Q8NF91
GLSNRTELLENHINF	TMEM132D	966	Q14C87
RGLTQELEQFHQEQL	NIN	756	Q8N4C6
LSIQADVHQFLLQGA	PLCE1	851	Q9P212
GNSAELRLVVQHEIN	RGPD2	546	P0DJD1
LGLEALAANHQQLFT	YARS2	146	Q9Y2Z4
LFHVVTDFNDNLISN	NPY5R	386	Q15761
ELEALHVVNQEALNA	ODAD3	261	A5D8V7
AGLFIDFVQRQIHNQ	POGZ	1101	Q7Z3K3
ANAHLVAAFEQSLGN	NAV2	1716	Q8IVL1
LTAFLVQISAHSDQN	ARHGAP1	371	Q07960
DFVQEHRLVLQSVAN	SIX4	706	Q9UIU6
HTLNQFDVVIRLNSA	ST3GAL5	211	Q9UNP4
LNIHVGNISLVDQFE	SMARCB1	266	Q12824
HEGVQAFLLQDQELL	TBATA	216	Q96M53
FEHNTQVRNQGIIAL	NSMCE4A	341	Q9NXX6
HYAVQGDNSQVLQLL	PLA2G6	191	O60733
LLGNFQLTNDEEIHN	TMEM150C	116	B9EJG8
LGDHSQAFLQAIADN	HERC2P3	111	Q9BVR0
GAFQQAAQILLHARE	SVEP1	171	Q4LDE5
LLQFQEEVFGKHVSN	SMARCC2	56	Q8TAQ2
LQEAVQFLTLHAASD	HES5	96	Q5TA89
HQVLFIADEIQTGLA	OAT	256	P04181
QEFAQLLAQSVNHGF	SMAD5	386	Q99717
QEFAQLLAQSVNHGF	SMAD1	386	Q15797
LLQAALEFHGVAQDL	SESTD1	376	Q86VW0
LEFHGVAQDLSQQLD	SESTD1	381	Q86VW0
HLQQNVQFSEDTVRL	STK32C	181	Q86UX6
ALGVSNFNHFQIERL	AKR1B15	156	C9JRZ8
QLRAVHEQLAALSQG	BRD2	526	P25440
NIGVSNFNHEQLERL	AKR1E2	166	Q96JD6
TQFLQELQLEHARQA	SLC25A12	151	O75746
IVLDNSVFSEHRNLQ	CLTC	1011	Q00610
IVLDNSVFSEHRNLQ	CLTCL1	1011	P53675
ANVVAHGFANLLTLD	CNGB3	606	Q9NQW8
LERAAENNVFHLVAT	SLC7A6OS	46	Q96CW6
VDGFHSEEQQLLLQV	GTF2A1	56	P52655
AVHFFTEELAIQQGQ	TRIM69	156	Q86WT6
DINQVLAHQLGSVFQ	TUBD1	226	Q9UJT1
QFVAESHIILVLNAA	TUSC3	276	Q13454
HGITQANELVNLTEF	CSE1L	446	P55060
ANELVNLTEFFVNHI	CSE1L	451	P55060
NTLVLHQTALVEAFN	TTC30B	241	Q8N4P2
HTFLVALNQTTNEDI	ZDHHC9	246	Q9Y397
LGEDFTQHIALTQNV	ZNF596	116	Q8TC21
AQEVLEFHQSLGALV	RBP3	626	P10745
LQGFTNQQAVEVLRH	MPDZ	436	O75970
ESVLRHLGIVDAFQQ	SERPINB9	281	P50453
DIQEVFQISDNHAGL	SPNS3	71	Q6ZMD2
FQISDNHAGLLQTVF	SPNS3	76	Q6ZMD2
VEALQGQVQHLQAAF	SFTPD	231	P35247
HFLGNNTVIDILRQA	TRABD2B	331	A6NFA1
IQGFANHDVVEVLRN	PATJ	426	Q8NI35
NLEALANHQEIQAAG	REXO5	391	Q96IC2
VLSAFNNILSNLGHV	SIDT1	491	Q9NXL6
ANVNDVHQATFLLAQ	STOML3	131	Q8TAV4
DLQSVNVGLFDQHFR	NISCH	1231	Q9Y2I1
NNIDSVHATAFIIVQ	PXDN	416	Q92626
GHNVFENDSFLQRVI	UGT1A1	96	P22309
QLNIHASEGINRFDV	TPP2	761	P29144
QLHSLAAVQQATIAA	PHC1	66	P78364
NDGNFHIVELLALDQ	SLIT2	1236	O94813
QQLAGEAEISHLALQ	TACC2	1476	O95359
EFILNHVDQIFNNGA	ARHGAP31	206	Q2M1Z3
FERELHLLGVQVQQF	SPTB	1841	P11277
HLLGVQVQQFQDVAT	SPTB	1846	P11277
GADNLVAINLIVQHI	UCK2	211	Q9BZX2
IVANEEGQQFALKLH	RIOK2	111	Q9BVS4
NLAVSNHVFQLRDSV	ZMIZ2	441	Q8NF64
VGESNHQAFILALLI	ZDHHC23	296	Q8IYP9
QEIRNSFFQSAHLIV	ZNF333	341	Q96JL9
SFSDVSVLDLHQQLQ	ZNF225	156	Q9UK10
SNAQRDVFNQLLIHA	TTC38	411	Q5R3I4
TIHNQDLLLRFENGV	ZXDA	166	P98168
NTLVLHQTALVEAFN	TTC30A	241	Q86WT1
QLDNAVSAFRHILIN	TRAPPC8	616	Q9Y2L5
GNNILHALVTVAEDF	TRPV3	296	Q8NET8
LGQQETLHVQERFVA	SLC25A23	271	Q9BV35
LISHNQAVVDDAQLD	ZNF831	411	Q5JPB2
HFAAVNSNNEIIITD	TRIM2	626	Q9C040
TAHFQITLNEIQAQL	TXLNG	241	Q9NUQ3
NNLLVNELDFADHGQ	TUT4	781	Q5TAX3
DVLLQHGANVNIQDA	TNNI3K	151	Q59H18
VASAGNVQHLIQAAL	ZHX3	396	Q9H4I2
SNFLGLEQLEHLDFQ	TLR4	416	O00206
ASELLDFIDNQGQVH	TTL	166	Q8NG68
VLNVVNNIFHGQLLS	USP44	461	Q9H0E7
QDAQEFFLHLVNLVE	USP13	446	Q92995
EASNQLINHIEQFLD	XRCC5	611	P13010
LTLNQHVEQLRGAFD	UTF1	301	Q5T230
DVLHFQFEQQGDVVL	ZBTB6	6	Q15916
VHIAIAQNTDAQAVL	SLC30A2	271	Q9BRI3
AQVAVGILRNHLTQF	AGL	856	P35573
AIVEAHQAEIAQLAN	LRRCC1	966	Q9C099
EGLSVVLQANHNLRE	NLRP12	931	P59046
VNSHVENFLDGALVL	SLC8A1	296	P32418
HVERINLGFNSIQAL	MXRA5	56	Q9NR99
NVTEQHFLTQLQELG	N4BP1	671	O75113